hg_222176.1

Basic information about the TSS

---

TSS ID: hg_222176.1 Species: human Chr: chr17		Start: 81870796 End: 81870797 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000579121.5 Distance: 133 GeneID: 396 HGNC/MGI_ID: HGNC:678 UniProt_ID: J3KTF8

Gene_name: Rho GDP dissociation inhibitor alpha Gene_symbol: ARHGDIA Gene_synonyms: RHOGDI Gene_source: HGNC:678

TATA-Box annotation

---

Distance to TSS:	200
Nearest PromoterID:	NM_001301241
Entrez ID:	396
Nearest Unigene:	Hs.159161
Nearest Refseq:	NM_004309
Nearest Ensembl:	ENSG00000141522
Gene Name:	Rho GDP dissociation inhibitor alpha
Gene Alias:	GDIA1|HEL-S-47e|NPHS8|RHOGDI|RHOGDI-1
Gene Description:	Rho GDP dissociation inhibitor alpha
Gene Type:	protein-coding
CpG%:	0.14
GC%:	0.791045
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ARHGDIA p2@ARHGDIA p3@ARHGDIA p4@ARHGDIA p5@ARHGDIA p6@ARHGDIA p7@ARHGDIA p8@ARHGDIA
Sample		p1@ARHGDIA	p2@ARHGDIA	p3@ARHGDIA	p4@ARHGDIA	p5@ARHGDIA	p6@ARHGDIA	p7@ARHGDIA	p8@ARHGDIA
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	101.88	10.71	5.84	6.43	3.31	3.31	2.73	4.48
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	102.58	7.89	7.89	4.65	4.45	1.21	1.82	4.05
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	100.31	9.65	10.22	5.21	4.82	1.93	3.28	3.09
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	81.92	6.45	6.65	5.61	2.70	3.74	2.70	1.87
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	86.39	6.52	7.42	5.40	4.72	2.02	2.47	2.92
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	88.77	8.14	6.78	7.17	3.68	2.13	2.13	1.94
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	121.14	9.80	11.77	14.82	6.10	3.49	4.14	5.01
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	107.55	11.14	8.48	7.51	3.39	4.12	3.88	2.18
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	118.83	11.54	7.69	7.05	4.70	2.78	2.14	2.56
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	64.34	6.96	7.54	3.48	0.00	2.90	0.58	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	70.74	6.47	4.04	5.66	4.04	0.81	0.40	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	61.80	4.07	4.88	2.85	2.44	1.63	2.85	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	82.05	3.39	3.39	2.74	4.19	2.10	2.10	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	79.54	3.61	3.76	3.31	4.06	1.35	1.50	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	70.26	2.42	2.42	2.42	2.20	1.10	1.54	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	72.43	3.77	5.28	4.02	4.02	2.01	1.26	2.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	58.97	3.71	2.84	3.06	2.18	1.97	0.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	58.63	8.44	5.48	2.11	3.80	1.69	2.53	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	59.71	2.67	5.33	4.80	3.73	2.13	1.07	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	65.44	3.91	2.41	3.61	1.81	2.26	0.90	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	74.18	3.34	4.54	1.87	2.27	1.47	0.94	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	76.99	3.28	3.97	4.14	2.93	2.59	2.07	2.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	74.32	5.43	5.17	4.91	3.23	2.20	1.16	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	68.67	5.82	3.15	2.67	2.91	1.94	1.70	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	66.05	4.64	3.87	2.84	2.32	2.06	1.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	65.52	4.43	3.17	2.53	3.80	1.27	0.32	1.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	49.45	6.04	6.59	2.20	3.30	2.20	1.10	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	100.19	4.24	2.83	4.95	4.01	1.18	2.59	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	64.77	5.98	2.75	4.52	2.26	1.45	0.97	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	80.17	4.89	5.25	4.16	3.26	2.90	1.27	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	73.90	5.44	5.02	4.40	2.09	2.09	1.05	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	70.34	4.69	4.10	3.91	4.49	0.98	0.59	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	66.05	3.80	6.96	3.80	6.12	2.32	1.90	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	77.36	8.74	8.25	6.27	4.45	5.44	1.32	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	86.95	4.86	5.42	4.11	3.55	2.24	2.06	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	80.48	3.26	5.37	3.64	2.68	1.92	1.15	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	83.39	5.52	3.88	4.29	1.84	2.86	2.66	1.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	90.06	6.65	4.84	4.03	3.63	3.43	2.82	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	85.62	5.67	3.78	3.51	4.05	2.16	1.62	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	77.30	5.04	3.60	5.04	3.36	1.68	1.92	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	88.22	4.71	4.23	4.47	3.29	2.59	0.71	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	75.98	6.29	4.68	5.71	4.10	2.93	2.20	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	86.47	4.85	3.59	5.27	3.37	2.74	1.27	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	78.32	4.20	5.94	4.37	3.67	2.10	1.40	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	91.15	3.81	3.61	5.02	3.41	1.81	2.61	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	83.29	6.51	3.95	6.98	3.95	3.02	2.33	1.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	83.01	3.60	4.32	3.60	4.80	1.44	1.44	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	72.43	2.09	3.28	2.09	3.87	2.09	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	91.20	4.07	2.15	3.35	2.87	1.44	2.87	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	82.70	3.84	3.03	4.65	2.63	2.43	0.81	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	70.50	5.94	12.71	4.10	5.33	4.71	2.25	2.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	79.17	5.11	6.00	6.45	3.34	1.56	1.11	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	363.80	0.00	0.00	41.98	0.00	0.00	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	80.91	4.97	5.32	2.48	3.90	1.42	0.71	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	80.86	5.30	6.30	2.65	3.31	1.99	2.65	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	79.70	21.81	21.81	12.58	5.03	3.36	5.87	4.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	55.11	7.81	13.32	5.97	4.13	5.51	2.76	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	89.45	5.83	9.40	1.62	5.83	2.59	1.62	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	70.01	4.18	5.14	1.93	2.89	0.96	1.28	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	72.61	8.17	6.92	5.03	4.40	2.83	1.89	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	80.38	5.64	7.05	3.53	2.82	2.12	2.82	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	81.88	7.85	6.17	0.56	2.24	4.49	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	64.49	2.39	6.37	9.55	3.98	3.98	0.80	3.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	52.66	3.40	9.51	3.74	2.04	1.36	2.04	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	90.00	2.92	4.87	2.60	3.57	3.57	3.57	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	82.00	7.81	4.61	2.13	1.77	3.55	2.13	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	226.30	0.00	16.16	32.33	16.16	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	189.54	7.90	7.90	39.49	0.00	0.00	15.79	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	107.74	11.70	10.73	1.95	3.41	1.95	3.41	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	94.22	7.93	5.95	2.48	2.48	1.98	2.48	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	94.76	5.16	6.57	0.94	2.35	0.94	2.35	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	74.19	4.31	6.62	4.64	1.66	2.98	0.66	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	85.07	9.90	8.04	2.78	3.40	2.17	3.40	1.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	90.50	7.34	5.50	2.14	3.06	1.22	2.75	1.22
Adipocyte - breast, donor1	11376-118A8	97.41	2.06	3.80	5.54	11.40	1.43	1.58	2.53
Adipocyte - breast, donor2	11327-117E4	115.35	10.27	15.24	7.38	6.26	8.98	4.33	1.60
Adipocyte - omental, donor1	11473-119C6	81.81	1.65	4.96	4.96	4.96	1.27	1.53	1.27
Adipocyte - omental, donor2	11474-119C7	117.36	5.98	4.48	4.48	2.99	2.99	3.74	2.24
Adipocyte - omental, donor3	11475-119C8	79.38	4.35	6.36	1.67	6.70	3.01	2.68	0.33
Adipocyte - perirenal, donor1	11476-119C9	105.91	7.02	6.38	5.10	2.55	2.55	4.47	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	78.06	5.50	9.90	5.50	11.00	0.00	2.20	2.20
Adipocyte - subcutaneous, donor2	11336-117F4	112.00	3.16	4.97	11.29	12.65	2.71	2.26	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	98.01	3.48	1.74	5.21	2.95	1.56	1.39	0.87
Adipocyte differentiation, day04, donor1	13019-139D4	117.54	1.96	1.96	2.54	2.35	0.78	1.56	0.98
Adipocyte differentiation, day04, donor2	13022-139D7	54.31	1.54	1.80	1.29	4.38	0.26	2.06	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	85.58	2.51	0.56	1.39	2.79	0.84	1.12	1.12
Adipocyte differentiation, day04, donor4	13028-139E4	68.77	0.59	1.18	1.18	2.35	0.59	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	115.34	2.01	1.61	2.25	3.70	0.64	1.21	0.48
Adipocyte differentiation, day08, donor2	13023-139D8	67.13	0.65	2.26	0.65	2.58	0.32	0.65	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	78.38	2.13	4.80	1.60	3.73	1.07	2.67	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	56.76	1.11	6.12	1.67	2.78	0.00	1.11	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	70.70	0.42	1.25	1.25	0.83	0.42	0.00	1.25
Adipocyte differentiation, day12, donor2	13024-139D9	72.08	3.52	1.51	1.51	2.01	0.50	0.75	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	59.56	2.62	3.27	0.98	3.93	1.96	0.98	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	53.89	0.30	0.61	1.22	0.61	0.30	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	230.50	3.98	3.54	0.88	1.99	1.55	2.21	2.65
Alveolar Epithelial Cells, donor2	11590-120G6	428.86	20.44	13.98	6.81	2.15	6.81	3.94	3.94
Alveolar Epithelial Cells, donor3	11671-122G6	116.21	3.59	0.00	3.59	0.00	1.20	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	134.57	3.24	1.44	1.62	0.36	1.98	0.36	1.44
Amniotic Epithelial Cells, donor2	11613-122A2	158.98	3.35	1.67	3.35	6.69	1.67	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	164.56	5.14	1.44	4.52	1.85	1.64	1.23	1.85
Anulus Pulposus Cell, donor1	11248-116E6	95.55	4.92	2.29	2.29	1.37	0.69	0.80	1.60
Anulus Pulposus Cell, donor2	11463-119B5	106.29	3.67	1.71	2.20	1.71	0.73	1.71	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	112.32	8.54	11.68	2.70	0.90	3.59	1.80	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	125.47	9.99	5.64	3.47	2.60	2.17	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	51.37	12.84	14.98	0.00	4.28	0.00	0.00	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	108.51	14.65	8.97	2.09	2.09	1.79	1.49	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	118.88	16.44	6.32	6.32	0.00	3.79	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	56.11	5.28	8.58	1.32	0.66	3.30	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	101.69	5.85	6.17	2.92	0.97	1.62	1.30	1.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	125.73	6.31	6.80	2.91	1.46	0.49	0.97	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	61.17	12.47	7.13	3.56	2.97	5.94	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	110.35	12.43	10.17	1.13	0.00	2.64	1.51	2.64
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	113.21	5.81	5.08	2.90	2.18	0.73	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	60.18	7.52	6.27	0.00	0.00	1.25	1.25	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	91.43	3.29	2.14	2.64	0.99	0.99	0.49	2.14
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	84.62	5.46	2.73	0.00	0.00	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	45.84	1.06	1.36	0.30	0.45	0.60	0.15	0.90
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	113.59	8.04	4.82	2.68	0.00	4.29	1.07	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	107.13	5.29	5.48	3.21	1.89	0.76	1.70	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	70.83	11.76	6.68	3.74	1.34	4.81	0.53	1.60
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	113.15	9.75	4.88	1.95	0.98	1.95	0.98	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	103.16	6.14	3.98	2.32	1.66	1.82	0.17	1.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	55.23	10.81	12.01	2.40	1.20	6.00	3.60	4.80
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	88.50	0.00	3.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	100.00	8.40	5.32	2.74	1.03	3.43	1.03	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	54.53	4.19	8.39	0.00	0.00	8.39	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	117.96	7.77	6.80	3.88	1.94	3.40	1.46	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	111.56	9.49	6.07	2.66	1.14	2.28	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	55.72	12.11	7.27	2.42	1.21	1.21	2.42	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	105.46	5.13	2.28	3.99	1.14	2.28	0.00	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	97.48	9.41	4.28	2.14	0.00	1.07	1.28	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	58.59	5.42	6.97	1.55	1.03	1.29	0.52	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	103.69	7.98	5.63	4.22	1.41	2.35	1.88	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	107.08	9.97	6.75	2.25	0.64	2.25	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	57.08	3.57	4.99	3.57	1.43	0.71	1.43	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	94.18	7.60	7.60	1.75	0.58	2.34	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	98.75	7.53	4.52	2.41	1.20	2.11	0.60	1.51
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	67.72	5.94	5.94	2.38	2.38	4.75	3.56	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	117.48	7.12	4.58	2.03	2.03	2.54	1.02	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	112.32	8.40	6.37	2.80	2.80	2.04	0.25	1.78
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	57.82	3.18	8.90	1.27	1.27	1.27	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	103.14	9.93	6.90	4.32	2.59	3.02	0.00	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	98.43	4.66	3.39	2.12	1.27	2.12	0.21	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	51.04	4.35	3.19	1.16	0.87	2.90	0.29	1.16
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	118.09	10.39	7.56	2.83	1.89	1.89	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	100.19	6.27	3.05	1.19	1.36	2.54	0.68	0.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	39.38	9.27	11.58	0.00	2.32	4.63	2.32	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	124.64	6.34	2.11	0.00	0.00	0.00	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	87.27	8.36	4.50	1.07	1.29	2.57	2.36	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	54.15	4.81	7.22	2.41	1.20	3.01	1.20	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	98.41	7.29	4.37	6.56	0.73	2.92	0.00	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	112.41	10.11	6.21	1.61	1.61	1.84	1.38	2.76
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	71.41	33.15	2.55	0.00	0.00	12.75	5.10	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	42.46	0.25	0.51	0.25	1.02	0.76	0.25	1.02
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	110.03	7.43	4.54	3.10	1.45	2.89	1.45	1.65
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	74.97	6.43	8.57	1.84	0.31	3.37	0.31	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	108.51	9.56	4.78	2.39	0.00	0.96	2.39	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	100.89	9.09	5.77	1.77	1.77	3.55	1.77	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	39.67	7.63	10.68	0.00	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	96.93	3.88	4.98	2.22	1.11	1.11	1.11	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	94.27	4.24	5.30	2.12	0.79	1.32	0.79	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	57.06	6.54	5.82	1.09	0.00	1.09	1.09	1.45
Astrocyte - cerebellum, donor1	11500-119F6	230.89	2.33	1.60	2.09	1.97	0.98	1.35	1.11
Astrocyte - cerebellum, donor2	11580-120F5	291.31	9.24	5.82	4.96	2.05	4.79	2.91	1.88
Astrocyte - cerebellum, donor3	11661-122F5	156.68	4.19	1.47	3.78	1.26	1.05	0.84	1.89
Astrocyte - cerebral cortex, donor1	11235-116D2	120.61	1.74	1.39	1.39	0.70	0.35	0.70	1.39
Astrocyte - cerebral cortex, donor2	11316-117D2	206.42	9.71	9.38	4.21	2.59	3.72	2.26	1.94
Astrocyte - cerebral cortex, donor3	11392-118C6	183.17	6.86	4.18	4.77	1.79	2.83	2.54	3.28
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	284.53	14.68	10.32	3.78	3.44	4.47	1.72	1.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	294.16	13.15	8.14	2.76	1.00	5.39	1.38	3.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	239.20	10.58	9.56	2.73	1.59	3.41	1.25	2.16
Basophils, donor1	12241-129G9	180.72	0.52	1.31	1.83	1.31	0.26	1.31	0.78
Basophils, donor2	12242-129H1	156.22	0.72	1.44	1.44	1.44	0.00	0.36	0.00
Basophils, donor3	12243-129H2	186.10	1.18	1.76	1.76	1.03	0.29	1.32	1.32
Bronchial Epithelial Cell, donor1	11511-119G8	101.55	2.37	2.37	0.86	1.08	0.43	1.08	0.86
Bronchial Epithelial Cell, donor2	11591-120G7	257.40	8.69	7.31	6.40	3.66	2.74	5.94	2.74
Bronchial Epithelial Cell, donor3	11672-122G7	114.78	7.17	7.17	0.00	0.00	0.00	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	254.83	5.02	4.39	5.65	11.30	3.77	3.14	1.88
Bronchial Epithelial Cell, donor5	11457-119A8	317.75	4.78	2.91	9.77	7.90	1.25	5.20	3.12
Bronchial Epithelial Cell, donor6	11461-119B3	164.43	4.15	2.53	5.76	5.07	0.46	4.84	1.61
Bronchial Epithelial Cell, donor7	11769-123I5	79.36	4.68	2.88	1.26	1.44	1.62	0.36	1.44
Burkitt's lymphoma cell line:DAUDI	10422-106C8	85.54	1.34	0.72	0.72	0.31	0.41	0.10	0.82
Burkitt's lymphoma cell line:RAJI	10476-106I8	99.92	3.49	2.33	0.47	0.70	0.70	1.63	1.63
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	94.33	1.60	1.60	1.92	0.32	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	51.71	0.00	10.34	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	163.99	2.82	1.69	0.00	0.56	0.00	1.13	1.13
CD14+ Monocytes, donor2	11305-117B9	200.08	5.38	6.50	2.60	1.11	4.64	1.30	0.56
CD14+ Monocytes, donor3	11381-118B4	164.65	1.76	2.20	2.20	2.20	1.54	0.66	1.98
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	110.67	3.11	0.85	4.25	10.76	0.85	1.70	1.13
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	121.68	1.90	2.65	2.27	7.96	0.76	1.90	1.90
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	136.10	2.30	2.30	3.94	7.56	1.31	3.29	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	161.75	7.81	14.74	7.37	6.07	8.67	4.05	2.60
CD14+ monocytes - mock treated, donor2	11873-125C1	151.17	2.11	9.05	7.54	4.22	2.11	3.02	2.72
CD14+ monocytes - mock treated, donor3	11883-125D2	158.24	1.42	6.63	4.03	4.03	2.61	4.03	1.18
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	153.34	4.69	12.22	4.35	3.85	5.69	1.67	3.35
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	147.11	2.21	5.80	4.69	1.93	1.38	2.21	1.66
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	185.20	1.49	3.97	4.21	1.98	2.73	1.24	2.98
CD14+ monocytes - treated with BCG, donor1	11860-125A6	156.64	10.18	12.14	2.74	1.96	5.48	2.35	2.94
CD14+ monocytes - treated with BCG, donor2	11870-125B7	134.78	1.78	4.99	2.49	1.25	2.31	0.89	2.49
CD14+ monocytes - treated with BCG, donor3	11880-125C8	162.13	1.52	7.18	3.48	1.09	1.96	1.96	4.35
CD14+ monocytes - treated with Candida, donor1	11868-125B5	143.75	2.81	4.21	4.68	4.68	1.87	0.94	1.87
CD14+ monocytes - treated with Candida, donor2	11878-125C6	156.82	0.53	1.58	2.11	3.70	1.06	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	194.14	3.33	5.55	2.22	3.33	0.00	1.11	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	151.72	6.84	15.02	7.88	4.16	7.44	3.87	2.53
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	157.04	2.00	9.98	9.98	7.18	4.59	1.20	3.19
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	119.30	2.08	4.37	4.37	4.79	1.46	2.91	1.46
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	179.60	7.09	9.84	9.61	7.55	7.32	4.35	3.20
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	147.26	1.13	3.85	9.73	7.24	2.04	2.26	4.30
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	148.40	2.62	4.36	12.22	7.86	0.87	1.31	2.18
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	138.53	6.72	9.95	4.57	3.50	4.84	2.42	1.88
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	179.00	1.92	6.63	5.23	3.49	3.14	2.97	2.62
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	190.63	3.37	5.89	5.47	3.79	2.52	3.37	4.21
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	187.39	9.00	12.86	4.04	2.39	4.41	2.94	4.04
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	165.92	2.47	7.05	3.87	1.76	1.41	2.11	2.47
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	202.69	3.51	7.46	4.83	5.26	3.07	1.32	4.83
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	142.11	4.01	9.94	3.84	1.92	3.84	1.92	1.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	139.01	1.49	4.83	2.97	0.74	2.97	1.86	2.97
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	159.08	3.02	4.53	2.59	1.72	2.16	1.29	2.16
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	151.92	6.14	12.28	5.73	2.46	3.69	2.05	3.69
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	128.42	0.70	4.40	2.78	1.85	1.62	2.32	2.09
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	113.44	1.62	6.73	1.86	2.09	1.86	1.39	2.32
CD14+CD16+ Monocytes, donor1	11789-124B7	96.78	1.96	2.18	2.40	1.74	1.31	1.09	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	119.66	3.93	4.16	5.54	4.16	0.92	1.62	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	80.80	1.30	1.30	1.52	1.08	0.43	0.43	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	149.49	2.80	2.02	4.20	2.02	0.78	0.93	2.49
CD14+CD16- Monocytes, donor2	11799-124C8	109.15	2.45	3.67	3.84	2.10	0.35	0.52	0.87
CD14+CD16- Monocytes, donor3	11910-125G2	137.13	1.56	4.68	2.01	1.34	1.34	1.34	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	102.58	0.26	0.77	1.53	0.77	0.26	0.26	1.28
CD14-CD16+ Monocytes, donor2	11800-124C9	111.32	3.95	2.42	4.39	1.76	0.88	1.32	1.54
CD14-CD16+ Monocytes, donor3	11911-125G3	90.96	0.84	1.05	2.11	1.47	0.42	0.21	1.89
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	93.49	0.00	0.00	2.03	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	98.31	0.68	2.03	2.71	1.36	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	93.20	2.07	0.00	0.00	2.07	1.04	0.00	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	80.49	0.00	0.00	2.13	1.07	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	123.83	1.61	1.07	2.68	3.22	1.61	0.54	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	95.46	0.70	1.40	0.70	0.00	0.00	1.40	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	98.04	0.78	0.78	1.57	1.57	0.00	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	112.05	0.00	0.00	0.00	0.00	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	166.02	2.47	0.00	1.64	2.47	1.64	1.64	0.00
CD19+ B Cells, donor2	11624-122B4	158.14	3.63	5.08	0.00	1.45	1.45	1.45	0.00
CD19+ B Cells, donor3	11705-123B4	191.33	2.52	1.51	3.53	3.03	1.01	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	26.26	0.81	0.81	0.81	0.40	0.81	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	21.57	1.20	0.00	0.00	0.40	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	53.21	1.00	1.00	1.00	1.00	0.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	92.70	0.00	1.69	0.56	2.81	0.56	0.56	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	103.71	0.75	0.38	1.50	0.75	0.00	0.38	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	90.64	0.90	0.45	1.35	0.00	0.00	0.23	0.90
CD4+ T Cells, donor1	11225-116C1	176.03	2.14	0.71	1.79	1.07	1.07	1.07	0.36
CD4+ T Cells, donor2	11306-117C1	178.81	14.08	14.08	7.35	3.06	3.06	1.22	3.06
CD4+ T Cells, donor3	11382-118B5	213.80	8.84	7.32	3.35	2.13	3.35	3.96	2.44
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	164.37	1.79	3.83	6.64	4.59	2.30	1.79	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	146.89	2.02	2.92	4.72	2.47	0.22	1.12	1.80
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	149.77	3.74	4.31	2.87	2.30	1.72	0.86	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	144.12	0.47	3.32	2.84	0.95	0.95	0.95	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	146.08	2.11	0.00	1.40	1.40	0.00	0.70	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	125.26	6.59	0.00	6.59	6.59	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	164.60	3.90	7.95	7.51	5.49	2.02	2.46	1.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	159.29	10.34	10.68	4.74	4.41	3.39	2.54	3.22
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	150.73	6.29	5.00	4.03	2.58	2.42	2.26	1.77
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	156.46	0.45	0.90	1.79	1.79	0.90	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	159.67	2.80	5.94	2.80	1.05	1.40	0.70	1.75
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	164.99	2.64	6.60	3.52	2.20	0.88	1.76	2.64
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	123.54	1.69	5.90	5.06	2.11	0.84	0.84	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	118.64	4.36	3.74	3.53	2.91	2.29	1.66	1.25
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	104.58	4.34	4.34	3.34	2.67	2.34	1.67	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	137.05	2.18	2.99	2.72	1.09	1.63	1.09	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	123.27	1.07	1.07	1.61	1.07	0.54	2.14	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	129.11	3.59	5.38	1.79	1.79	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	197.48	2.41	5.19	5.19	1.85	1.11	2.04	2.04
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	185.64	4.55	4.55	6.50	3.03	1.95	1.08	1.95
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	207.00	3.99	8.20	5.46	5.04	2.31	1.89	1.26
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	142.07	3.54	2.02	2.02	4.04	0.51	1.01	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	155.97	1.30	1.30	5.20	2.17	0.43	1.30	1.30
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	182.17	3.49	4.79	3.05	0.44	1.31	2.18	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	169.25	2.97	1.98	3.46	1.98	0.49	1.98	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	134.79	3.69	0.92	3.69	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	135.39	0.00	0.00	4.19	2.79	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	181.11	3.32	4.15	3.88	3.05	0.55	1.66	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	197.29	0.74	2.70	3.19	2.21	1.23	1.47	1.72
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	126.28	0.00	0.00	1.54	0.00	0.00	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	182.64	3.22	2.15	3.58	3.22	1.07	2.51	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	170.35	6.92	2.77	1.38	1.38	1.38	2.77	0.00
CD8+ T Cells, donor1	11226-116C2	202.00	3.60	1.96	2.29	2.95	1.96	0.98	1.64
CD8+ T Cells, donor2	11307-117C2	230.89	12.01	9.01	7.88	3.00	5.63	2.63	1.50
CD8+ T Cells, donor3	11383-118B6	228.76	5.81	3.53	5.55	1.77	2.02	1.51	1.26
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	70.42	3.44	3.21	2.75	0.23	2.06	1.84	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	65.42	3.35	3.35	3.35	0.24	2.40	1.20	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	51.98	6.57	5.75	3.83	1.09	3.01	2.19	1.09
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	94.57	6.00	5.70	3.60	2.10	0.30	1.80	1.50
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	82.31	5.52	6.48	3.12	1.68	1.44	0.96	1.20
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	78.90	5.91	3.64	1.82	0.91	1.36	3.41	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	56.71	3.69	2.82	2.39	0.87	0.22	0.87	1.09
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	49.75	5.26	5.00	2.63	1.05	1.58	1.32	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	48.54	4.22	3.52	2.58	2.35	1.17	1.17	1.64
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	60.38	4.23	5.43	1.81	1.51	0.60	1.21	1.51
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	42.99	3.78	5.23	2.61	1.74	0.58	1.16	1.45
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	59.68	3.73	2.40	2.66	0.27	0.53	1.07	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	39.40	1.75	1.75	0.44	1.31	0.44	0.00	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	36.89	1.37	1.37	0.91	0.00	0.00	0.91	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	44.01	0.00	1.49	0.00	0.00	0.00	0.75	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	77.79	4.32	3.96	3.60	2.16	2.52	0.36	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	70.78	5.75	2.30	1.73	0.29	2.01	1.15	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	71.18	4.71	3.30	4.71	1.89	1.18	1.41	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	72.25	5.07	2.54	2.22	0.63	1.90	0.63	1.90
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	55.36	3.08	4.00	3.38	0.92	0.92	1.23	1.23
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	55.14	3.53	1.60	0.64	0.32	0.32	0.96	2.24
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	40.92	3.82	1.15	1.53	0.76	1.53	0.38	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	42.96	0.79	0.79	2.36	1.58	0.00	0.79	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	31.01	2.27	4.54	4.54	0.00	1.51	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	50.59	0.80	1.61	1.61	0.80	0.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	38.47	2.10	0.70	0.00	1.40	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	51.09	2.00	7.01	3.01	2.00	3.01	1.00	2.00
Cardiac Myocyte, donor1	11525-119I4	104.18	0.00	1.83	1.83	0.00	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	102.28	3.95	2.47	3.46	0.49	1.48	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	146.69	2.95	1.58	0.74	1.26	0.63	0.53	1.05
Chondrocyte - de diff, donor1	11261-116G1	101.23	5.55	4.85	1.04	4.51	4.51	0.35	0.69
Chondrocyte - de diff, donor2	11338-117F6	136.46	1.78	4.62	4.98	8.88	0.71	3.55	2.13
Chondrocyte - de diff, donor3	11410-118E6	117.76	7.17	5.01	3.87	2.96	4.21	1.93	1.59
Chondrocyte - re diff, donor2	11339-117F7	210.39	1.79	2.69	4.48	6.27	1.79	0.00	5.37
Chondrocyte - re diff, donor3	11411-118E7	125.37	3.64	0.40	2.83	2.02	0.00	2.02	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	103.51	3.33	1.61	1.95	0.92	1.26	0.80	1.49
Ciliary Epithelial Cells, donor2	11323-117D9	125.05	6.20	4.06	2.57	0.86	2.78	1.71	1.28
Ciliary Epithelial Cells, donor3	11399-118D4	127.97	5.31	1.86	2.83	0.88	1.77	0.97	1.59
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	132.87	2.66	2.48	2.93	2.11	1.10	0.73	1.38
Corneal Epithelial Cells, donor1	11526-119I5	140.97	1.76	2.20	1.76	1.10	0.44	0.88	1.10
Corneal Epithelial Cells, donor2	11606-120I4	80.77	3.41	5.69	4.55	1.14	4.55	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	156.70	4.35	2.81	4.09	0.77	2.56	1.79	1.53
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	68.02	0.83	0.50	0.83	1.16	0.17	0.50	0.66
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	73.49	1.26	0.95	0.95	1.58	0.00	0.63	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	58.66	6.90	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	106.48	3.56	2.05	1.62	0.97	0.97	1.08	1.62
Dendritic Cells - plasmacytoid, donor1	11228-116C4	139.05	0.68	1.71	0.00	1.71	0.34	0.68	1.71
Dendritic Cells - plasmacytoid, donor2	11309-117C4	141.02	1.31	0.00	1.31	1.96	0.00	0.00	1.96
Dendritic Cells - plasmacytoid, donor3	11385-118B8	144.22	0.48	0.97	1.45	0.00	0.00	0.00	1.94
Endothelial Cells - Aortic, donor0	11207-116A1	256.32	1.00	2.00	5.17	3.67	0.67	2.84	4.84
Endothelial Cells - Aortic, donor1	11263-116G3	199.50	2.35	3.52	4.11	4.11	1.17	1.76	4.69
Endothelial Cells - Aortic, donor2	11340-117F8	171.66	4.81	3.39	0.28	2.55	1.13	1.70	4.52
Endothelial Cells - Aortic, donor3	11412-118E8	162.39	1.57	0.39	4.72	4.33	0.39	2.36	3.54
Endothelial Cells - Artery, donor1	11264-116G4	195.76	6.98	6.98	7.27	5.53	5.53	0.87	3.49
Endothelial Cells - Artery, donor2	11341-117F9	256.22	28.94	21.18	5.88	7.76	11.29	2.35	3.29
Endothelial Cells - Artery, donor3	11413-118E9	347.29	2.98	3.86	11.22	10.17	1.93	6.49	7.54
Endothelial Cells - Lymphatic, donor1	11236-116D3	97.53	1.77	1.33	2.22	0.89	0.44	0.44	1.55
Endothelial Cells - Lymphatic, donor2	11317-117D3	124.45	1.22	2.74	2.74	2.74	1.22	1.22	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	126.86	0.56	1.41	1.41	2.82	1.41	1.41	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	160.45	7.43	7.13	3.86	6.83	2.67	1.78	1.19
Endothelial Cells - Microvascular, donor2	11342-117G1	180.67	2.60	1.04	5.21	11.45	1.04	1.56	3.12
Endothelial Cells - Microvascular, donor3	11414-118F1	158.94	10.21	6.38	3.83	6.24	5.25	1.99	1.84
Endothelial Cells - Thoracic, donor1	11266-116G6	203.26	7.20	3.20	2.40	4.80	1.20	1.20	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	148.85	15.72	17.30	1.57	8.91	7.34	2.62	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	161.02	6.83	4.72	5.72	3.48	1.86	2.11	2.86
Endothelial Cells - Umbilical vein, donor2	11324-117E1	111.46	3.69	1.30	0.87	2.39	0.22	1.30	1.96
Endothelial Cells - Umbilical vein, donor3	11400-118D5	161.45	3.05	2.20	2.08	1.71	1.10	1.10	2.08
Endothelial Cells - Vein, donor1	11267-116G7	328.74	3.41	2.28	5.69	6.83	1.14	2.28	0.00
Endothelial Cells - Vein, donor2	11344-117G3	319.21	2.10	3.49	18.16	14.67	0.00	2.10	4.89
Endothelial Cells - Vein, donor3	11416-118F3	216.67	2.04	3.30	5.50	2.83	0.63	3.45	3.61
Eosinophils, donor1	12244-129H3	60.99	0.00	0.00	0.00	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	298.70	1.65	3.30	0.00	3.30	1.65	1.65	6.60
Eosinophils, donor3	12246-129H5	278.21	3.57	3.57	0.00	3.57	0.00	7.13	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	117.77	1.71	1.47	0.98	1.22	0.49	0.24	1.22
Esophageal Epithelial Cells, donor2	11587-120G3	114.41	2.08	4.16	0.00	2.08	2.08	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00	0.00	0.00	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	105.91	1.23	2.46	2.05	2.05	0.00	0.82	2.05
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	70.07	17.52	12.26	3.50	8.54	4.60	3.72	5.15
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	105.52	23.62	14.08	7.37	7.58	6.72	2.38	1.95
Fibroblast - Aortic Adventitial, donor1	11245-116E3	170.40	11.04	8.85	7.16	9.10	3.40	3.15	4.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	100.17	1.36	2.73	1.50	0.82	0.55	0.68	1.23
Fibroblast - Aortic Adventitial, donor2	11326-117E3	147.66	9.81	14.34	8.54	8.96	7.91	4.96	2.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	117.25	6.85	5.80	2.63	2.63	2.63	2.63	1.32
Fibroblast - Aortic Adventitial, donor3	11401-118D6	220.58	14.62	10.96	7.31	7.97	7.31	8.97	3.32
Fibroblast - Cardiac, donor1	11268-116G8	156.50	4.08	6.35	4.99	2.72	3.63	2.27	2.27
Fibroblast - Cardiac, donor2	11345-117G4	260.73	5.31	5.31	10.61	14.40	0.00	3.79	6.06
Fibroblast - Cardiac, donor3	11417-118F4	166.86	13.09	9.46	7.10	5.84	7.10	3.31	3.00
Fibroblast - Cardiac, donor4	11452-119A3	131.25	1.21	0.30	3.03	1.82	0.61	0.61	2.73
Fibroblast - Cardiac, donor5	11456-119A7	154.06	6.47	4.31	3.68	3.43	1.52	2.16	1.40
Fibroblast - Cardiac, donor6	11460-119B2	172.82	5.91	3.49	2.12	1.36	2.88	2.88	1.67
Fibroblast - Choroid Plexus, donor1	11492-119E7	161.19	1.74	1.47	1.74	1.21	0.54	0.80	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	105.70	2.16	1.29	0.43	0.86	2.16	0.43	1.29
Fibroblast - Choroid Plexus, donor3	11653-122E6	186.03	13.18	10.25	2.93	0.00	2.93	1.46	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	190.05	1.15	2.08	1.38	0.69	0.46	1.61	1.85
Fibroblast - Conjunctival, donor3	11692-122I9	98.03	3.39	1.87	2.37	1.53	1.19	0.68	1.36
Fibroblast - Dermal, donor1	11269-116G9	120.68	5.17	5.17	3.76	3.99	0.70	1.41	1.17
Fibroblast - Dermal, donor2	11346-117G5	275.93	1.89	2.83	2.83	7.55	0.00	1.42	3.77
Fibroblast - Dermal, donor3	11418-118F5	147.60	8.46	4.96	5.92	4.23	3.14	1.93	2.30
Fibroblast - Dermal, donor4	11450-119A1	189.58	11.08	6.78	3.39	1.24	3.62	2.94	2.03
Fibroblast - Dermal, donor5	11454-119A5	192.07	8.72	2.97	4.71	1.57	2.79	1.57	1.92
Fibroblast - Dermal, donor6	11458-119A9	236.98	15.11	7.80	4.55	1.62	3.57	2.60	2.76
Fibroblast - Gingival, donor1	11237-116D4	115.78	3.54	2.50	0.62	1.04	1.25	0.42	2.71
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	177.11	3.93	8.38	18.86	15.20	2.62	1.05	2.36
Fibroblast - Gingival, donor2	11318-117D4	211.25	23.85	9.88	6.59	2.11	5.80	3.29	2.90
Fibroblast - Gingival, donor3	11394-118C8	130.33	4.83	2.32	2.13	1.26	2.42	1.55	1.55
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	147.52	7.27	5.19	3.12	7.27	2.08	0.00	3.12
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	112.59	11.81	5.99	7.40	8.63	3.00	2.82	1.06
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	207.97	6.39	2.96	6.86	3.43	1.87	3.12	3.59
Fibroblast - Gingival, donor6 (control)	11922-125H5	196.89	10.82	10.41	10.82	6.49	5.41	3.65	2.98
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	534.61	5.29	10.59	33.17	30.70	3.53	6.35	9.17
Fibroblast - Gingival, donor7 (control)	11924-125H7	139.22	6.29	5.85	8.19	4.97	2.92	1.46	2.92
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	142.22	6.95	9.68	7.50	3.82	3.68	2.86	1.36
Fibroblast - Gingival, donor8 (control)	11926-125H9	181.65	7.90	7.46	8.78	4.17	3.07	3.73	2.85
Fibroblast - Gingival, donor9 (control)	11927-125I1	114.16	3.08	6.75	13.50	10.12	2.35	3.08	2.20
Fibroblast - Lung, donor1	11270-116H1	299.06	4.08	2.72	8.16	4.08	0.00	0.00	5.44
Fibroblast - Lung, donor2	11347-117G6	138.77	2.98	0.00	1.49	4.48	0.00	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	241.64	18.99	10.76	3.59	4.85	6.12	2.74	3.38
Fibroblast - Lymphatic, donor1	11506-119G3	389.85	0.83	4.17	2.50	3.33	1.67	2.50	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	226.58	1.40	2.80	8.39	1.40	1.40	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	168.49	5.04	5.04	3.64	1.68	3.08	3.08	1.68
Fibroblast - Mammary, donor1	11540-120B1	325.99	2.44	1.62	4.47	2.84	1.62	2.44	2.44
Fibroblast - Mammary, donor2	11620-122A9	307.55	19.97	15.98	3.99	0.00	3.99	7.99	3.99
Fibroblast - Mammary, donor3	11701-123A9	178.69	0.00	0.00	0.00	5.96	5.96	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	167.59	3.30	2.33	1.94	1.36	1.16	2.33	1.55
Fibroblast - Periodontal Ligament, donor2	11319-117D5	261.04	19.42	9.56	5.46	1.82	7.13	5.76	3.03
Fibroblast - Periodontal Ligament, donor3	11395-118C9	207.46	1.84	0.92	3.06	1.84	1.22	0.00	2.75
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	170.59	4.58	8.40	3.05	1.14	2.29	1.91	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	174.14	12.96	7.29	7.29	4.05	6.48	2.97	2.97
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	114.12	4.75	4.29	5.57	4.06	2.55	2.55	1.62
Fibroblast - Pulmonary Artery, donor1	11250-116E8	145.68	5.64	2.87	3.09	1.55	0.88	1.11	3.43
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	265.16	2.24	4.88	2.44	2.24	3.25	1.42	2.44
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	243.89	6.01	3.34	5.35	1.34	4.01	3.34	3.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	143.52	9.88	3.56	2.77	1.58	3.16	1.19	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	216.51	7.54	9.72	3.18	1.19	3.77	0.60	1.59
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	81.53	1.78	1.95	1.95	2.31	0.53	1.07	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	101.30	2.17	1.97	0.79	2.37	1.58	0.20	1.97
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	133.88	3.61	4.21	2.41	0.90	2.11	1.20	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	166.25	6.80	6.69	2.48	3.02	3.35	2.16	1.19
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	156.15	7.34	4.81	2.28	1.27	2.53	1.01	1.01
Fibroblast - skin normal, donor1	11553-120C5	125.19	2.30	3.28	2.79	4.10	1.48	2.13	1.31
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	139.55	1.80	2.81	1.00	0.40	1.00	0.80	0.60
Fibroblast - skin normal, donor2	11561-120D4	203.54	8.44	10.75	3.42	4.12	3.21	3.42	1.31
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	214.89	6.65	3.93	1.51	1.21	3.02	0.60	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	90.96	1.49	2.57	2.07	1.99	1.74	0.91	1.74
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	130.44	4.44	5.47	2.05	3.42	1.03	1.54	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	150.42	1.64	2.96	2.96	0.00	2.63	0.99	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	252.78	8.73	9.05	4.47	3.94	4.47	2.56	1.49
Fibroblast - skin walker warburg, donor1	11554-120C6	194.66	5.74	6.41	3.37	1.69	2.02	1.35	2.36
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	110.71	23.21	11.92	7.84	2.82	5.96	4.08	2.35
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	310.24	0.00	22.16	132.96	0.00	0.00	22.16	44.32
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	64.49	0.87	0.87	0.87	1.74	0.87	1.74	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	111.99	0.69	2.08	6.24	6.41	1.21	2.25	2.77
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	134.80	1.04	1.82	3.90	4.68	0.78	1.30	1.82
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	131.33	0.77	2.04	4.85	5.88	1.02	1.28	2.56
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	40.57	3.83	3.83	3.83	5.36	1.53	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	68.91	2.55	6.38	3.83	5.10	3.83	3.83	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	63.90	3.71	5.99	6.56	4.56	3.42	0.57	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	38.88	2.21	3.86	9.10	11.31	1.10	0.00	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	51.37	1.60	2.51	7.99	11.87	1.37	0.46	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	55.87	5.15	4.36	5.94	5.15	2.58	1.39	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	48.11	2.11	2.91	6.87	11.63	0.53	1.06	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	55.44	1.63	0.98	3.26	11.09	2.28	0.65	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	44.22	3.98	3.10	3.98	1.77	1.33	1.33	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	84.93	4.66	3.82	1.70	1.55	1.13	0.57	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	89.89	3.32	4.56	3.20	1.48	1.85	0.62	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	75.75	6.45	3.76	2.69	1.88	1.88	1.34	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	147.43	5.45	7.56	5.70	3.35	3.47	0.87	1.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	138.29	7.20	4.43	3.74	3.18	2.63	0.97	1.11
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	101.04	5.49	8.54	4.88	2.03	4.68	1.22	1.02
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	111.81	8.21	4.56	4.56	5.70	3.88	0.46	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	110.24	5.23	2.62	2.24	3.24	2.49	1.37	1.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	111.69	3.28	3.93	1.31	2.62	1.53	1.09	1.75
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	117.31	9.46	9.16	5.32	3.84	4.14	0.59	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	112.70	6.52	4.13	3.02	1.75	1.11	0.64	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	109.48	4.24	2.90	3.35	2.90	2.01	0.45	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	129.05	12.90	10.28	4.23	4.84	4.84	2.62	1.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	135.37	8.31	5.43	4.41	2.37	1.87	1.19	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	118.73	2.93	4.97	5.59	3.90	2.66	0.80	1.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	207.28	1.56	4.68	14.36	5.93	2.29	0.62	1.14
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	174.02	1.20	3.76	7.86	6.49	1.20	1.37	2.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	131.35	5.75	2.88	3.10	4.09	2.66	0.66	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	105.58	2.75	3.00	3.74	2.58	1.50	1.00	1.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	101.89	1.63	2.45	3.27	2.86	0.61	0.82	1.02
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	108.10	8.87	7.01	5.36	3.71	3.09	0.62	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	118.41	5.65	4.04	2.77	1.96	1.73	0.69	1.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	152.59	10.34	5.17	3.17	3.67	3.50	2.00	1.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	121.46	9.04	8.16	7.05	4.63	1.32	1.10	1.32
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	141.07	9.22	5.78	4.06	3.94	3.20	0.74	1.35
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	130.00	9.40	6.32	4.70	3.40	4.38	1.78	1.95
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	104.87	6.41	3.85	6.09	5.77	2.89	2.25	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	137.77	7.96	4.64	3.32	4.55	2.08	1.90	0.95
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	144.57	7.28	5.38	4.75	4.43	3.32	1.90	1.58
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	139.88	9.73	6.08	9.12	6.99	5.17	0.91	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	151.16	7.74	6.17	6.38	3.97	2.61	1.99	1.15
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	120.32	6.37	6.59	2.42	2.42	4.39	1.32	2.42
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	122.88	6.73	4.49	4.49	3.37	1.40	0.56	1.40
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	168.88	1.67	5.37	8.06	8.06	1.67	1.20	1.20
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	153.22	12.03	8.56	8.56	4.81	5.88	1.87	3.74
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	172.28	11.02	7.50	4.13	2.60	5.05	1.22	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	166.58	9.33	5.57	4.66	4.02	3.50	1.17	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	153.97	5.69	4.34	4.61	3.80	2.98	0.27	2.71
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	123.33	13.27	10.32	4.06	3.13	3.69	1.11	2.21
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	119.74	8.77	5.48	3.73	3.95	3.07	1.10	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	186.45	4.96	6.94	6.94	3.97	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	148.27	9.89	6.46	5.14	2.90	4.35	1.45	1.19
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	123.68	7.47	6.05	3.23	2.62	4.04	1.82	1.21
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	217.05	0.00	1.02	3.81	1.27	2.03	0.51	1.52
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	93.56	3.58	2.79	1.39	1.19	0.40	1.00	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	91.52	3.24	2.77	1.39	1.69	1.69	0.46	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	90.63	3.07	1.43	0.82	2.05	1.02	0.41	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	38.18	1.56	0.94	0.94	0.94	0.31	0.31	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	39.28	0.85	0.57	1.70	1.70	0.57	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	47.04	2.31	0.92	0.46	1.38	0.92	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	56.92	2.47	7.42	2.47	4.95	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	76.59	4.64	5.42	6.58	6.19	3.48	2.71	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	60.97	0.00	0.00	4.81	6.42	1.60	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	74.77	0.00	0.00	0.00	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	58.59	2.28	3.91	2.60	4.56	3.25	0.65	2.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	66.30	3.29	3.29	5.35	2.88	2.06	1.65	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	29.99	3.33	6.66	10.00	6.66	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	49.78	2.52	2.24	3.08	3.64	2.52	0.56	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	62.75	1.96	3.92	5.23	4.58	2.94	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	54.52	0.84	2.52	3.36	2.52	1.68	0.00	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	61.07	2.23	4.13	5.09	3.82	2.86	0.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	60.80	2.72	4.76	3.40	1.70	0.68	1.36	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	56.38	2.09	4.18	2.09	2.09	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	67.01	4.58	4.01	3.44	5.15	4.58	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	59.20	4.74	1.78	1.48	2.66	1.18	0.59	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	47.44	0.00	3.39	3.39	1.69	0.00	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	89.05	10.36	6.21	4.14	6.21	1.24	2.07	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	74.33	3.22	4.60	4.14	2.99	3.68	0.92	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	31.61	10.54	0.00	10.54	5.27	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	56.12	3.08	3.08	1.92	2.31	0.77	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	51.18	4.56	2.93	4.24	3.91	2.61	0.98	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	45.48	2.01	3.34	2.01	3.34	2.01	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	77.05	6.16	4.62	5.78	5.01	1.93	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	84.56	5.48	3.77	7.53	5.82	1.71	1.37	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	54.67	2.48	2.48	2.48	0.00	0.00	0.00	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	47.19	2.83	3.77	6.61	5.19	3.30	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	47.07	1.81	4.83	3.02	3.62	3.62	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	52.90	3.56	5.60	1.02	7.63	0.00	1.02	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	63.81	5.98	4.79	2.79	4.39	3.19	0.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	57.72	4.93	2.47	5.92	2.47	1.48	0.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	66.10	1.18	2.36	0.00	0.00	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	51.34	1.75	3.50	1.17	5.25	1.17	0.00	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	65.39	3.07	3.07	5.71	3.07	1.76	0.44	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	54.25	3.39	1.70	3.39	4.24	1.70	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	50.14	4.78	3.58	0.60	2.98	0.00	1.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	53.86	4.37	3.40	1.46	2.43	1.46	0.49	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	192.88	1.14	2.28	5.71	4.57	1.14	0.00	5.71
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	155.52	24.53	10.81	3.74	4.57	6.24	1.25	2.49
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	454.28	6.75	4.50	29.24	28.11	4.50	1.12	9.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	125.60	7.61	4.44	1.27	1.59	1.59	0.63	2.22
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	108.20	5.85	2.92	1.25	1.67	2.51	0.42	1.67
Hep-2 cells mock treated, biol_rep1	11898-125E8	107.92	11.14	4.87	3.02	1.51	2.55	0.93	0.81
Hep-2 cells mock treated, biol_rep2	11899-125E9	115.63	7.76	6.92	2.19	1.69	2.03	2.19	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	101.01	4.32	5.01	1.82	0.91	3.19	0.91	2.05
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	113.57	11.81	7.98	4.15	2.08	2.62	2.51	1.75
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	120.14	9.67	6.66	1.93	1.50	3.87	1.93	1.29
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	100.97	4.74	7.10	1.29	0.86	1.72	0.86	1.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	109.09	8.72	5.23	2.24	1.12	3.49	1.37	1.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	103.27	6.00	3.95	1.89	0.86	2.23	1.72	1.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	104.12	9.29	6.41	2.24	1.92	2.24	1.28	2.56
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	210.98	8.39	6.16	11.19	5.60	5.60	4.48	3.36
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	267.03	8.22	7.79	9.95	7.36	4.33	6.06	2.16
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	174.49	15.86	34.37	2.64	7.93	26.44	0.00	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	168.25	1.76	1.06	2.47	1.06	0.71	0.71	3.53
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	162.74	2.18	2.91	5.81	3.63	2.18	0.73	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	164.00	10.67	8.57	2.80	1.22	3.15	1.22	2.10
Hepatocyte, donor1	11523-119I2	94.43	0.00	3.63	8.47	3.63	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	92.65	6.46	2.15	11.85	4.31	4.31	0.00	4.31
Hepatocyte, donor3	11684-122I1	59.51	0.00	0.61	11.04	3.68	0.61	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	97.90	6.53	2.61	2.61	1.31	0.65	1.96	2.61
Intestinal epithelial cells (polarized), donor1	11246-116E4	91.94	3.32	2.27	2.45	1.75	1.22	0.52	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	112.78	3.16	1.65	1.10	0.55	0.55	1.10	0.82
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	133.72	6.37	9.55	3.18	0.00	3.18	0.00	6.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	166.88	6.68	0.00	0.00	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	243.75	0.00	27.08	0.00	0.00	27.08	0.00	27.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	137.05	1.38	6.92	1.38	1.38	4.15	1.38	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	132.64	12.51	0.00	5.01	0.00	2.50	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	201.76	23.74	23.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	220.41	12.81	2.56	2.56	0.00	2.56	5.13	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	95.99	0.00	4.57	0.00	0.00	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	207.91	14.62	8.12	3.25	0.00	4.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	143.39	8.34	13.34	1.67	1.67	10.00	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	94.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	239.55	23.82	14.56	1.32	2.65	1.32	1.32	5.29
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	140.80	7.76	14.41	3.33	0.00	3.33	2.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	115.24	5.24	5.24	0.00	0.00	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	166.28	11.97	5.04	3.78	1.26	3.15	1.89	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	162.40	1.55	1.55	3.09	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	73.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	207.38	16.15	11.63	3.88	0.65	4.52	0.65	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	181.92	14.49	4.83	1.61	4.83	4.83	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	83.64	0.00	11.95	0.00	11.95	0.00	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	192.31	18.74	11.41	2.44	1.63	7.33	1.63	2.44
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	184.30	9.24	4.62	4.20	1.68	2.94	0.00	2.10
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	71.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	184.85	16.07	11.25	2.41	3.21	1.61	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	150.49	5.54	6.46	4.62	0.92	2.77	1.85	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	151.52	10.86	9.44	1.89	2.36	3.30	1.89	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	143.30	9.07	8.16	5.44	0.91	7.26	2.72	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	132.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	156.04	19.37	11.84	2.15	1.08	4.30	2.15	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	181.68	16.52	8.89	2.54	1.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	115.01	0.00	0.00	0.00	16.43	0.00	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	168.35	10.20	11.48	3.83	3.83	9.57	3.19	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	180.44	7.29	14.58	3.65	0.00	5.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	190.66	19.99	13.57	7.85	2.86	5.71	0.71	2.14
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	192.46	9.95	19.91	3.32	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	146.61	10.19	5.86	2.47	2.16	2.47	0.93	1.23
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	237.06	10.54	14.05	1.76	1.76	1.76	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	194.87	12.57	3.14	0.00	0.00	0.00	3.14	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	170.37	14.60	9.74	1.39	2.09	2.78	2.78	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	208.03	6.64	2.21	2.21	2.21	6.64	4.43	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	197.76	0.00	0.00	3.24	0.00	6.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	190.08	8.72	5.23	5.23	1.74	1.74	5.23	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	170.98	4.50	4.50	2.25	0.00	2.25	2.25	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	191.65	3.48	0.00	0.00	6.97	6.97	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	151.48	13.87	8.53	3.20	2.13	5.33	1.07	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	198.12	6.93	5.54	1.39	2.77	5.54	4.16	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	173.83	11.40	5.70	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	218.14	12.89	7.36	3.68	0.92	2.76	0.00	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	184.54	12.10	6.05	3.03	0.00	0.00	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	155.22	18.63	0.00	0.00	0.00	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	133.23	9.52	7.40	4.23	0.00	3.17	2.11	3.17
Keratinocyte - epidermal, donor1	11272-116H3	119.62	7.43	9.55	3.59	6.04	3.43	1.22	2.77
Keratinocyte - epidermal, donor2	11349-117G8	197.36	1.17	1.76	2.93	4.10	1.17	1.76	1.76
Keratinocyte - epidermal, donor3	11421-118F8	198.78	9.09	6.15	4.54	1.61	3.41	1.61	2.18
Keratinocyte - oral, donor1	11251-116E9	143.03	6.81	4.31	2.27	0.79	1.36	1.02	2.16
Keratocytes, donor1	11527-119I6	253.06	2.41	3.44	1.72	2.75	1.38	1.38	4.13
Keratocytes, donor2	11607-120I5	189.83	4.69	3.52	7.03	2.34	2.34	3.52	4.69
Keratocytes, donor3	11688-122I5	111.84	2.77	4.15	1.38	2.17	1.78	0.59	1.58
Krukenberg tumor cell line:HSKTC	10687-109F3	37.36	0.00	4.40	0.00	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	149.95	7.55	8.63	2.16	0.00	4.31	1.08	1.08
Lens Epithelial Cells, donor2	11609-120I7	106.68	1.04	0.46	0.58	0.81	0.35	0.58	0.81
Lens Epithelial Cells, donor3	11690-122I7	80.93	0.50	0.30	0.20	0.30	0.10	0.40	0.50
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	172.41	6.17	4.51	5.69	3.32	2.13	2.73	2.49
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	111.91	4.19	2.51	5.58	3.35	2.23	1.12	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	120.42	3.94	2.68	5.19	3.31	2.68	2.68	1.73
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	114.53	2.69	5.38	3.76	1.61	0.00	1.08	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	113.14	3.47	3.78	3.47	1.89	1.58	0.32	1.89
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	131.10	5.39	4.74	7.98	2.70	3.45	2.26	1.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	107.93	4.10	2.46	4.51	1.64	1.64	1.23	1.23
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	146.38	5.81	3.54	10.11	2.02	2.02	1.01	1.52
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	137.65	4.64	2.11	8.16	2.39	3.10	2.53	2.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	112.73	3.96	5.54	6.72	1.98	1.58	1.19	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	119.82	3.10	2.71	7.56	1.36	1.94	2.71	1.94
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	148.12	3.70	2.59	5.92	2.41	2.04	1.85	2.96
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	108.36	1.39	3.83	5.57	1.39	2.09	2.09	2.44
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	140.97	2.62	2.86	7.16	1.67	2.15	1.43	1.67
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	137.07	7.69	5.49	9.20	1.79	2.88	2.20	1.24
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	131.50	4.31	3.08	6.78	2.46	0.92	0.92	3.08
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	125.63	5.61	2.81	8.42	1.56	2.18	3.12	2.81
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	164.33	3.48	3.66	8.05	4.03	2.38	2.01	2.20
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	124.07	4.28	2.30	5.92	1.32	1.32	1.65	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	142.04	3.51	3.81	8.20	2.64	1.76	2.93	3.51
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	155.83	5.23	5.97	10.46	2.74	4.23	2.49	2.49
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	108.63	5.82	2.91	5.33	1.94	2.42	0.00	2.42
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	138.15	5.12	3.77	7.54	1.35	1.89	1.08	1.35
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	136.85	6.66	4.84	11.66	3.03	3.18	2.88	1.97
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	97.98	3.63	3.63	3.63	2.59	2.07	1.04	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	135.69	4.19	2.72	5.44	2.30	1.68	1.88	1.47
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	144.21	4.06	4.66	6.92	2.86	3.46	2.11	1.95
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	106.62	5.50	2.75	6.19	1.38	2.75	2.06	2.06
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	125.87	3.95	3.39	5.46	1.32	1.88	2.82	0.94
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	144.62	7.74	5.30	8.69	2.86	3.71	2.76	2.12
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	109.03	3.39	2.91	3.88	0.97	1.45	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	114.45	2.32	3.31	8.93	2.32	2.65	0.99	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	148.55	6.07	6.19	7.43	2.48	3.22	1.61	2.60
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	115.14	3.70	3.33	6.29	2.22	1.85	1.11	1.85
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	108.72	2.96	1.24	8.65	1.98	2.72	1.24	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	143.82	6.05	4.12	11.14	2.75	3.30	1.65	2.20
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	100.99	4.18	2.25	5.47	0.96	0.32	2.89	1.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	120.82	3.04	3.96	8.22	2.74	3.65	1.22	1.52
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	123.59	5.18	2.66	9.24	2.66	2.38	1.96	1.82
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	100.98	4.98	2.13	3.56	2.49	2.84	1.07	2.49
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	122.65	5.82	6.30	9.70	4.36	1.45	2.91	1.45
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	157.94	6.07	3.89	9.03	2.65	3.42	2.65	1.71
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	114.24	5.01	7.88	4.30	2.15	3.94	1.07	1.07
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	129.36	3.27	1.63	8.82	3.92	0.65	0.98	1.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	137.96	3.30	3.77	5.41	2.12	2.59	2.83	1.88
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	189.71	4.95	3.22	4.95	2.97	2.23	3.22	3.71
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	158.29	2.56	1.28	5.38	3.33	1.79	2.05	3.84
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	150.97	3.58	2.98	4.77	3.58	3.58	2.69	2.98
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	129.16	0.00	2.27	0.00	0.00	0.00	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	158.03	5.37	8.44	1.53	0.77	3.84	3.07	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	119.50	3.71	3.71	2.23	2.23	3.71	2.23	2.23
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	121.86	11.42	17.77	4.65	5.08	5.08	2.12	2.54
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	128.00	9.14	9.85	2.81	5.63	4.92	3.52	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	148.50	5.60	8.41	1.87	5.60	2.80	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	90.69	14.94	25.25	5.15	2.58	10.31	2.58	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	151.06	11.89	14.27	5.95	1.19	2.38	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	139.11	4.07	4.52	3.62	2.26	0.45	2.26	1.13
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	87.25	11.34	10.76	5.82	2.62	6.98	2.62	2.04
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	125.15	7.65	9.90	3.15	2.25	4.50	0.90	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	171.66	7.86	11.25	4.61	2.98	3.12	3.52	3.12
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	114.00	12.84	14.38	4.62	3.59	6.16	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	132.67	6.70	8.12	3.18	1.41	1.06	2.47	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	103.94	4.00	4.66	2.67	1.33	4.00	2.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	107.48	14.77	13.75	6.11	3.57	6.62	0.51	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	143.27	8.00	7.47	2.93	1.33	3.74	1.60	1.87
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	130.37	11.34	9.26	3.59	3.21	4.35	3.40	2.83
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	122.71	20.86	11.04	7.98	2.45	6.75	0.61	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	239.73	13.05	17.94	2.45	2.45	4.08	2.45	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	134.53	13.54	13.12	2.92	3.54	4.58	1.87	1.67
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	87.72	10.37	10.65	6.45	2.52	5.61	3.08	2.24
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	189.58	5.15	5.15	4.12	1.03	3.09	2.06	3.09
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	139.35	13.93	10.74	3.19	3.19	5.52	2.90	2.61
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	81.31	11.06	7.17	5.08	1.79	2.09	3.89	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	125.59	6.64	9.41	0.55	2.21	4.43	2.21	2.77
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	187.70	17.67	19.09	3.89	3.18	6.36	3.53	2.12
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	97.73	12.17	10.33	4.06	0.74	4.79	2.21	2.58
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	109.37	9.21	5.76	10.36	2.30	2.30	2.30	4.61
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	183.82	16.12	13.82	3.07	3.07	6.52	3.07	1.54
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	107.56	15.29	23.21	9.06	3.96	6.23	5.10	5.10
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	155.07	7.38	11.49	8.20	3.28	3.28	3.28	2.46
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	170.81	14.46	17.62	2.71	4.52	4.97	5.42	1.81
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	112.75	12.93	15.08	2.87	3.59	4.31	6.46	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	177.02	11.20	11.20	4.48	0.75	5.23	3.73	3.73
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	198.06	23.04	27.13	6.69	2.60	7.43	7.06	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	100.79	8.18	8.18	3.45	0.43	4.74	1.72	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	208.08	15.41	6.85	8.56	2.57	7.71	5.99	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	199.57	19.66	13.99	5.33	3.00	9.66	2.67	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	118.25	16.29	10.86	1.81	4.22	3.62	1.81	2.41
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	172.77	6.40	3.55	5.69	4.98	3.55	5.69	4.27
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	167.73	17.53	16.84	3.78	4.47	3.78	2.75	2.06
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	114.86	12.88	13.42	2.68	2.15	2.15	1.07	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	160.93	8.08	13.47	10.10	2.69	8.75	1.35	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	165.20	21.48	17.04	5.19	4.82	7.78	3.33	2.22
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	108.15	2.33	1.16	4.65	4.65	1.16	3.49	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	150.20	12.69	8.46	1.06	2.12	4.23	4.23	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	152.86	15.61	16.81	4.80	6.40	5.20	3.60	2.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	110.48	5.81	14.54	2.18	1.45	3.63	1.45	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	190.86	6.13	7.67	3.07	1.53	5.37	3.83	2.30
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	180.05	15.29	13.81	5.92	3.95	7.89	1.97	2.96
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	88.45	11.29	13.17	6.59	8.47	7.53	4.70	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	185.04	7.04	5.03	3.02	2.51	3.02	4.53	2.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	168.98	10.36	14.87	4.51	4.96	9.46	5.41	2.25
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	80.89	10.33	15.49	3.44	6.88	5.16	3.44	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	168.34	14.25	16.03	4.45	1.78	4.90	3.56	2.67
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	158.76	14.47	19.55	2.74	2.74	7.04	4.30	3.91
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	95.00	11.22	9.24	5.28	5.28	3.30	3.96	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	166.58	8.30	4.67	5.19	4.67	3.11	1.56	2.08
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	179.84	19.25	21.44	6.13	5.25	7.00	5.25	3.06
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	96.17	8.39	7.27	6.15	4.47	6.71	2.24	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	154.13	7.07	6.62	3.09	3.53	3.97	2.21	1.77
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	168.56	18.51	12.73	5.79	4.63	4.24	3.86	2.70
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	101.27	12.15	9.62	4.05	4.05	5.57	1.52	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	173.50	6.25	9.61	4.81	2.88	2.40	1.44	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	151.86	15.50	14.71	5.57	5.57	3.98	3.18	3.18
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	99.65	9.11	14.58	6.08	1.82	7.90	4.86	3.04
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	112.75	10.38	6.23	2.08	0.69	1.38	2.08	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	155.42	17.48	11.40	5.70	4.94	5.32	3.42	2.66
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	116.19	14.46	17.56	4.65	2.58	8.26	1.55	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	141.49	10.28	14.51	2.42	3.63	4.84	3.02	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	176.83	14.58	12.99	6.97	4.12	4.44	3.17	1.90
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	101.82	10.66	9.60	3.20	1.60	3.73	2.13	2.67
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	154.59	12.07	6.90	5.17	2.30	1.72	2.87	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	177.93	15.43	19.03	4.11	4.63	7.71	4.63	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	126.62	14.85	22.64	4.95	5.66	9.90	2.12	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	164.00	14.75	9.08	7.38	3.40	7.94	4.54	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	193.87	23.71	19.97	2.91	5.41	6.66	4.58	4.58
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	151.13	22.71	16.44	10.18	6.26	10.18	6.26	5.48
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	172.86	17.95	13.36	3.76	2.09	7.10	2.51	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	188.18	21.37	12.08	6.04	1.86	8.36	3.72	2.79
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	141.84	18.73	13.38	7.36	4.68	7.36	1.34	2.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	174.29	20.85	16.04	5.88	4.81	5.35	2.14	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	224.68	29.09	24.65	7.27	5.25	8.49	3.64	4.45
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	149.60	14.68	11.01	2.75	0.00	4.59	2.75	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	217.83	16.00	23.12	8.89	8.00	10.67	6.22	3.56
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	253.02	23.36	21.66	10.26	2.28	3.99	3.99	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	161.82	15.34	10.74	6.14	3.83	6.14	2.30	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	184.95	12.04	15.32	4.38	6.57	6.57	3.83	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	266.82	19.60	16.93	8.46	4.90	9.35	5.35	5.79
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	221.48	9.88	8.58	7.80	5.46	2.08	3.12	6.24
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	237.39	9.28	11.94	5.97	3.32	2.65	3.98	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	263.98	27.02	33.26	6.24	10.39	8.31	2.08	4.16
Macrophage - monocyte derived, donor1	11232-116C8	102.56	1.60	0.68	0.91	0.46	0.68	0.46	2.05
Macrophage - monocyte derived, donor2	11313-117C8	100.93	1.84	1.28	1.65	0.55	0.73	0.55	0.92
Macrophage - monocyte derived, donor3	11389-118C3	132.39	3.41	2.75	2.75	1.05	1.70	1.18	1.05
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	81.78	0.00	1.06	0.53	0.53	0.53	0.00	2.12
Mallassez-derived cells, donor2	11929-125I3	128.82	3.64	6.18	5.86	3.80	2.54	1.74	2.54
Mallassez-derived cells, donor3	11930-125I4	150.11	6.39	5.56	5.00	1.67	2.50	3.06	1.95
Mammary Epithelial Cell, donor1	11273-116H4	86.99	1.79	1.89	1.10	0.70	0.60	0.30	1.49
Mammary Epithelial Cell, donor2	11350-117G9	124.80	6.08	1.74	1.45	0.58	1.16	0.58	1.16
Mammary Epithelial Cell, donor3	11422-118F9	302.31	4.99	2.00	7.23	3.74	1.00	2.99	3.74
Mast cell - stimulated, donor1	11487-119E2	75.93	4.75	0.68	0.68	18.30	0.68	1.36	2.03
Mast cell, donor1	11563-120D6	162.75	2.38	3.78	7.35	7.14	1.62	1.19	1.30
Mast cell, donor2	11565-120D8	288.85	5.35	13.97	21.40	31.50	3.86	4.75	4.46
Mast cell, donor3	11566-120D9	306.17	3.38	9.46	18.46	18.01	4.28	4.50	3.38
Mast cell, donor4	11567-120E1	313.80	4.08	11.88	20.57	29.61	4.25	4.43	4.43
Mast cell, expanded and stimulated, donor5	11940-126A5	136.07	2.88	5.54	5.77	5.10	3.44	1.11	1.22
Mast cell, expanded and stimulated, donor8	11942-126A7	44.36	1.75	6.42	4.09	7.59	2.33	1.17	0.58
Mast cell, expanded, donor5	11939-126A4	145.93	4.24	8.03	8.83	12.05	2.29	2.18	2.06
Mast cell, expanded, donor8	11941-126A6	96.91	3.35	8.37	8.87	11.88	3.51	1.34	1.67
Melanocyte - dark, donor1	11502-119F8	136.01	3.98	1.59	1.99	1.79	1.19	0.50	1.59
Melanocyte - dark, donor2	11582-120F7	87.21	5.19	4.15	1.38	1.04	1.73	1.04	0.35
Melanocyte - dark, donor3	11663-122F7	264.19	3.77	2.54	1.74	1.52	1.09	1.30	1.88
Melanocyte - light, donor1	11274-116H5	252.23	10.58	6.11	10.81	18.10	3.29	10.81	3.29
Melanocyte - light, donor2	11351-117H1	333.73	6.14	3.41	35.49	59.37	2.73	6.14	5.46
Melanocyte - light, donor3	11423-118G1	277.51	5.20	1.73	15.61	23.42	1.73	5.20	5.20
Melanocyte, donor1 (MC+1)	12641-134G4	242.72	14.27	11.14	7.08	3.96	5.00	2.29	2.60
Melanocyte, donor2 (MC+2)	12739-135I3	140.39	7.80	4.84	6.19	2.69	1.61	1.34	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	181.34	9.64	10.45	4.29	5.62	4.55	1.61	2.14
Meningeal Cells, donor1	11493-119E8	390.91	4.47	4.59	2.48	1.49	2.98	3.60	1.98
Meningeal Cells, donor2	11573-120E7	227.56	4.84	6.16	4.40	2.20	3.52	0.44	0.44
Meningeal Cells, donor3	11654-122E7	210.36	9.29	9.94	2.45	0.90	4.08	1.96	2.85
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	172.80	5.13	2.28	2.57	1.71	1.71	0.29	2.28
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	62.69	1.71	1.11	0.91	0.81	0.50	0.70	0.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	275.97	0.00	3.94	1.31	11.83	0.00	2.63	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	228.93	7.85	1.31	1.31	1.31	1.31	3.92	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	165.05	12.92	5.74	3.59	2.15	2.87	2.87	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	98.68	2.96	5.72	2.33	4.66	1.48	0.85	2.75
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	119.63	4.02	5.03	4.52	3.02	5.03	2.51	2.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	243.27	5.71	3.30	1.98	1.10	1.10	2.20	3.74
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	250.59	6.58	6.58	7.31	2.19	1.46	2.92	2.19
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	271.92	10.43	5.93	6.75	1.84	3.07	3.27	2.66
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	116.07	2.22	0.97	1.11	1.11	0.69	0.55	0.97
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	158.73	1.86	2.60	2.97	3.72	1.12	1.12	2.60
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	100.00	3.29	2.76	2.24	1.18	1.18	0.53	2.89
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	99.70	2.08	4.15	1.48	1.48	0.89	0.89	2.37
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	102.76	2.34	2.34	7.01	0.00	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	179.31	2.56	4.48	2.56	0.00	1.28	2.56	1.92
Mesenchymal stem cells - adipose, donor0	11217-116B2	155.96	2.84	2.84	2.84	1.06	0.35	0.00	2.48
Mesenchymal stem cells - hepatic, donor0	11218-116B3	108.83	3.44	2.19	2.19	0.94	0.63	0.00	1.56
Mesenchymal stem cells - umbilical, donor0	11214-116A8	169.81	6.53	2.18	2.90	0.73	2.18	2.18	2.18
Mesothelial Cells, donor1	11247-116E5	96.52	1.59	1.59	3.98	9.28	1.06	1.86	1.33
Mesothelial Cells, donor2	12156-128G5	91.08	2.00	2.00	2.00	1.00	1.00	1.50	1.00
Mesothelial Cells, donor3	11402-118D7	112.88	5.42	5.28	4.19	2.38	3.18	1.66	1.30
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	66.17	0.00	1.35	0.00	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	102.94	1.23	2.22	1.72	2.46	0.99	1.48	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	91.87	1.47	1.77	1.77	2.06	0.59	1.18	0.88
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	89.88	0.00	3.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	80.59	0.62	2.79	0.62	2.48	0.62	0.00	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	75.71	2.07	1.45	0.62	0.83	0.62	0.83	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	78.75	0.00	0.00	0.00	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	99.85	3.75	2.00	1.75	3.25	1.25	0.50	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	80.99	0.93	1.86	0.47	0.47	0.00	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	97.33	0.00	0.00	0.00	19.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	100.39	3.86	4.67	1.02	2.03	0.20	1.22	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	70.48	2.38	1.98	0.00	0.79	0.40	0.79	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	102.62	0.00	0.00	0.00	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	95.57	3.54	8.85	1.77	2.65	4.42	2.65	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	83.97	2.28	2.66	2.28	0.76	1.90	0.00	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	63.16	1.32	0.00	0.00	3.95	0.00	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	103.78	4.46	2.97	2.55	2.12	0.85	1.70	0.85
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	40.52	0.00	0.92	0.00	0.92	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	78.09	2.98	4.17	0.89	1.49	0.89	1.79	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	45.27	0.00	3.35	0.00	1.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	203.70	0.00	0.00	0.00	33.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	91.58	2.76	5.27	4.01	2.26	1.25	1.00	1.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	68.92	2.61	0.71	0.48	1.19	0.95	0.71	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	65.24	0.00	1.11	0.00	0.00	0.00	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	79.20	2.76	2.07	3.45	2.07	1.61	0.23	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	78.88	0.42	1.47	1.68	1.89	0.42	1.47	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	86.83	2.45	1.83	1.22	1.22	1.43	0.61	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	76.80	1.50	3.00	2.36	1.50	1.29	0.64	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	76.69	0.89	1.33	0.89	1.56	0.22	0.67	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	123.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	75.56	2.19	2.63	1.53	1.75	0.88	0.44	0.88
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	48.67	0.51	0.00	0.00	0.51	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	72.91	0.00	1.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	76.65	1.63	1.09	1.36	1.36	0.00	1.09	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	69.11	0.59	1.47	0.29	0.59	0.59	0.88	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	62.15	0.00	4.36	0.00	6.54	1.09	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	87.46	3.84	4.81	1.92	1.92	2.88	0.48	1.92
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	81.25	0.80	3.60	1.60	2.00	0.40	0.00	2.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	102.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	123.64	6.01	6.01	1.50	0.50	1.50	1.00	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	75.42	0.00	2.04	0.00	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	78.83	4.82	4.82	1.31	0.88	0.00	0.44	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	69.53	0.00	0.00	0.00	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	99.90	0.00	0.64	0.00	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	108.84	3.47	5.45	0.99	1.74	1.98	1.98	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	61.93	0.00	0.70	0.70	2.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	95.02	0.00	0.00	0.00	2.21	0.00	0.00	4.42
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	122.05	5.47	6.50	1.71	1.71	1.71	1.71	1.03
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	70.89	0.88	0.88	0.00	0.88	0.88	0.44	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	87.71	0.36	0.36	0.71	0.71	0.00	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	118.39	2.24	5.61	2.52	2.52	2.81	3.09	1.68
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	84.79	0.00	0.00	0.83	0.00	0.42	0.00	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	99.65	0.00	3.50	0.00	1.17	0.58	0.58	1.75
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	108.90	3.92	4.83	0.60	1.81	3.32	0.90	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	104.77	0.00	1.25	0.42	2.09	0.83	1.25	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	93.84	0.00	0.00	0.00	0.00	0.00	0.00	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	98.82	1.85	2.77	0.92	2.77	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	69.43	1.71	1.71	0.00	1.71	0.00	1.14	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	96.31	1.24	1.24	0.83	0.97	0.14	0.00	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	103.14	1.55	4.66	2.33	3.37	2.07	1.30	1.30
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	73.35	0.43	1.29	0.86	0.86	0.00	0.43	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	89.56	0.00	0.64	0.00	1.27	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	73.66	0.80	1.07	1.07	0.27	0.27	1.07	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	75.43	0.90	1.80	1.80	0.30	0.30	0.60	1.80
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	77.41	1.13	0.57	0.71	0.71	0.28	0.14	0.85
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	92.05	3.50	5.10	1.91	2.55	1.91	0.96	1.91
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	75.18	1.55	0.88	0.22	0.88	0.00	0.22	1.11
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	92.15	0.38	0.38	0.00	0.38	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	90.35	2.27	1.70	0.28	0.57	0.85	1.42	1.70
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	86.52	1.97	2.70	2.21	1.23	0.25	0.74	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	78.20	0.00	2.61	0.00	0.65	0.65	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	72.04	0.59	1.47	1.47	2.94	0.00	0.59	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	83.04	2.31	3.75	0.86	0.86	1.44	0.00	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	48.63	1.65	0.82	0.41	1.24	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	86.36	0.30	1.19	2.08	0.30	0.30	0.60	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	56.50	3.77	0.00	0.00	0.00	0.00	3.77	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	49.90	1.78	0.00	0.00	0.00	1.78	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	111.71	5.59	7.89	0.99	1.64	4.27	2.96	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	104.14	2.10	4.21	1.05	2.10	1.05	2.10	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	50.21	0.79	1.98	0.59	0.59	0.99	0.79	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	77.30	1.86	1.86	0.00	0.00	0.00	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	119.04	3.76	4.13	3.00	7.89	1.88	3.38	2.25
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	83.63	1.86	5.86	2.13	1.60	0.53	1.86	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	67.52	1.13	1.92	0.45	1.92	0.34	0.79	0.79
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	95.77	5.16	7.37	0.74	0.00	3.68	1.47	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	97.84	3.66	2.56	1.10	1.83	2.93	1.83	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	118.23	9.33	7.78	1.56	1.56	1.56	1.56	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	72.68	1.60	2.14	2.67	0.53	0.53	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	88.87	15.46	15.46	0.00	3.86	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	126.24	8.08	10.10	2.02	4.04	3.03	1.01	3.03
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	84.33	1.69	2.95	1.26	0.42	2.11	0.84	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	27.24	1.36	0.00	1.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	20.98	0.64	1.27	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	17.82	0.00	0.81	0.00	0.81	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	48.33	1.51	1.51	3.02	3.02	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	79.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	52.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	71.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	87.84	0.00	0.00	0.00	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	146.07	3.88	6.68	3.02	2.80	1.72	0.86	3.45
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	105.05	5.23	5.23	3.14	2.61	3.66	2.09	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	115.48	8.68	5.34	3.34	2.67	0.00	2.67	2.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	121.87	0.42	5.43	1.25	2.09	0.83	1.25	1.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	114.85	6.85	5.89	6.85	1.14	2.09	2.28	2.28
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	150.01	3.19	6.38	0.00	6.38	0.00	1.60	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	82.27	0.68	4.76	0.00	2.04	2.04	1.36	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	169.06	9.19	9.19	51.45	0.00	0.00	5.51	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	51.90	2.51	2.93	2.09	2.93	0.00	0.84	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	101.81	5.11	4.18	2.09	0.93	0.23	0.46	2.56
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	87.55	4.86	2.70	1.89	1.62	0.81	1.35	1.08
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	92.50	1.47	2.10	1.68	2.31	0.42	0.21	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	233.83	0.00	11.13	22.27	0.00	0.00	33.40	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	69.49	5.96	3.97	1.99	1.99	0.50	1.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	37.89	2.71	1.35	1.35	1.62	0.81	1.08	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	59.39	3.85	5.89	2.49	1.59	1.81	1.59	1.13
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	69.40	1.96	1.63	0.65	1.63	1.47	0.49	0.98
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	82.20	4.01	4.01	2.19	1.09	1.64	2.00	1.28
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	63.65	2.65	2.12	1.06	2.65	1.06	2.65	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	58.23	3.60	0.60	0.00	1.80	0.00	1.20	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	30.19	2.63	5.25	4.27	0.66	3.28	1.31	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	53.83	2.93	2.44	1.14	2.60	0.98	0.98	0.98
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	66.67	2.47	1.76	1.76	1.06	0.71	0.18	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	48.52	2.11	0.70	1.41	0.00	0.00	0.70	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	46.43	2.30	0.92	0.00	1.38	0.00	1.84	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	46.27	1.29	1.93	0.96	1.61	0.64	0.96	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	64.15	8.97	6.21	6.55	1.38	2.07	3.79	2.76
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	214.92	0.00	0.00	37.93	0.00	7.59	2.53	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	67.06	0.89	0.89	0.89	0.89	0.22	0.22	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	44.46	2.12	1.69	0.00	2.12	1.27	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	44.86	2.37	2.85	1.19	1.66	0.24	0.71	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	58.81	4.29	2.15	0.86	1.72	0.00	0.86	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	234.72	0.00	0.00	18.06	0.00	0.00	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	56.98	2.33	2.33	1.00	1.00	0.33	0.67	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	53.65	0.45	1.80	0.00	0.45	0.00	0.45	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	35.32	5.16	3.17	1.59	1.98	0.79	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	54.79	4.64	4.64	0.93	1.86	0.93	5.57	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	46.54	3.41	2.65	1.89	0.76	0.76	0.76	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	60.61	3.58	3.58	0.98	1.63	1.30	1.30	1.63
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	65.80	2.61	1.31	0.44	0.00	0.00	1.31	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	50.20	0.90	0.90	0.00	0.90	0.45	0.90	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	51.15	2.65	3.53	0.00	1.76	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	47.20	1.99	2.66	1.33	1.33	0.00	2.66	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	64.98	3.97	2.98	0.99	0.99	0.99	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	60.49	1.53	3.45	0.77	1.15	0.38	1.15	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	54.14	1.81	1.21	2.12	1.51	0.91	0.91	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	61.00	1.55	1.55	0.66	0.22	0.66	0.22	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	33.88	3.39	1.36	0.68	2.03	1.36	0.68	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	112.41	5.11	0.00	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	48.77	3.05	2.44	0.00	2.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	43.43	0.94	1.57	0.94	0.00	0.63	0.31	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	59.62	2.42	1.21	0.91	0.61	0.30	0.30	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	45.89	3.16	2.37	0.79	3.16	0.79	3.16	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	53.28	2.27	6.80	10.20	0.00	1.13	2.27	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	60.69	15.17	5.06	35.41	0.00	0.00	5.06	0.00
Myoblast, donor1	11241-116D8	104.35	4.60	2.48	3.35	1.49	1.12	1.61	3.60
Myoblast, donor2	11322-117D8	129.84	12.66	6.52	4.99	2.49	4.60	2.11	1.92
Myoblast, donor3	11398-118D3	158.91	4.20	1.68	3.20	1.68	1.85	1.18	2.35
NK T cell leukemia cell line:KHYG-1	10777-110G3	209.41	3.94	2.04	1.17	2.04	0.73	1.02	2.04
Natural Killer Cells, donor1	11230-116C6	161.75	3.38	1.85	3.08	1.23	1.23	2.15	0.31
Natural Killer Cells, donor2	11311-117C6	197.22	9.95	9.05	4.22	4.22	3.92	3.62	1.81
Natural Killer Cells, donor3	11387-118C1	201.17	5.71	2.58	5.89	3.87	2.21	2.94	1.29
Neural stem cells, donor1	11275-116H6	174.94	2.18	12.70	18.51	17.06	4.36	2.18	2.18
Neural stem cells, donor2	11352-117H2	204.12	0.00	1.93	1.93	9.63	0.00	1.93	1.93
Neurons, donor1	11494-119E9	171.82	5.69	7.97	0.00	0.00	4.55	1.14	1.14
Neurons, donor2	11574-120E8	161.38	5.94	2.20	1.98	0.66	1.76	0.22	1.76
Neurons, donor3	11655-122E8	99.48	13.15	13.15	3.29	2.47	4.93	2.47	4.11
Neutrophils, donor1	11233-116C9	217.15	10.21	5.57	8.35	12.06	6.50	1.86	2.78
Neutrophils, donor2	11314-117C9	226.11	28.99	2.90	14.49	34.79	14.49	14.49	5.80
Neutrophils, donor3	11390-118C4	236.40	1.22	4.89	11.61	11.61	4.89	0.61	4.89
Nucleus Pulposus Cell, donor1	11252-116F1	104.37	4.63	2.02	1.42	1.19	1.07	1.31	1.42
Nucleus Pulposus Cell, donor2	11409-118E5	83.03	6.19	4.56	2.28	1.30	3.91	0.98	1.63
Nucleus Pulposus Cell, donor3	11462-119B4	124.94	3.61	2.01	1.80	1.20	2.01	0.80	0.00
Olfactory epithelial cells, donor1	11933-125I7	74.74	7.98	5.51	1.10	1.79	1.38	1.10	0.69
Olfactory epithelial cells, donor2	11934-125I8	89.89	25.48	15.49	1.88	3.18	7.24	2.32	3.04
Olfactory epithelial cells, donor3	11935-125I9	67.99	8.29	4.99	1.36	1.36	2.38	1.14	1.02
Olfactory epithelial cells, donor4	11936-126A1	91.36	5.26	3.02	1.75	1.75	2.05	0.58	0.88
Oligodendrocyte - precursors, donor1	11496-119F2	193.18	1.81	3.01	3.01	0.00	4.21	0.60	3.01
Osteoblast - differentiated, donor1	11276-116H7	204.61	1.49	1.70	12.12	17.23	0.64	2.77	2.13
Osteoblast - differentiated, donor2	11353-117H3	97.16	0.00	5.72	11.43	17.15	0.00	4.57	4.57
Osteoblast - differentiated, donor3	11425-118G3	122.90	6.21	4.97	3.72	8.69	2.48	3.72	0.62
Osteoblast, donor1	11277-116H8	267.75	2.35	1.56	3.32	4.89	1.17	2.74	3.52
Osteoblast, donor2	11354-117H4	167.15	7.02	6.32	3.51	3.51	1.40	0.70	4.21
Osteoblast, donor3	11426-118G4	316.72	1.42	1.78	8.71	4.09	1.07	1.96	5.33
Pancreatic stromal cells, donor1	11249-116E7	156.26	9.01	6.65	6.91	5.73	3.37	3.62	3.12
Pericytes, donor1	11491-119E6	186.59	2.89	2.56	3.12	5.23	1.56	1.45	1.78
Pericytes, donor2	11571-120E5	171.81	7.24	4.53	3.40	1.81	4.07	2.49	0.68
Pericytes, donor3	11652-122E5	207.11	8.34	5.49	5.29	2.24	4.88	2.64	2.24
Perineurial Cells, donor1	11499-119F5	176.09	3.05	0.90	1.81	1.36	0.45	0.68	1.36
Perineurial Cells, donor2	11579-120F4	124.21	1.38	1.20	2.30	0.46	0.74	1.10	1.38
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	151.40	3.19	1.27	3.51	1.91	1.27	0.64	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	134.67	10.28	8.08	3.67	3.67	3.92	1.47	1.96
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	170.44	7.12	4.92	5.82	1.55	3.49	2.46	1.42
Placental Epithelial Cells, donor1	11278-116H9	147.09	2.15	3.35	4.54	7.89	1.20	0.00	0.96
Placental Epithelial Cells, donor2	11355-117H5	181.86	5.54	5.54	1.11	6.65	6.65	1.11	1.11
Placental Epithelial Cells, donor3	11427-118G5	156.87	9.42	5.69	4.52	3.34	2.94	1.96	1.57
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	118.04	27.21	17.40	8.54	7.28	11.08	4.75	2.53
Preadipocyte - breast, donor1	11467-119B9	74.47	2.81	4.69	3.56	6.38	1.13	0.94	0.94
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	131.83	1.57	1.44	0.78	0.78	1.04	0.91	0.78
Preadipocyte - breast, donor2	11328-117E5	145.67	11.03	13.96	7.88	5.18	3.38	5.40	2.03
Preadipocyte - omental, donor1	11468-119C1	76.51	2.66	6.50	4.16	5.43	1.70	2.34	1.17
Preadipocyte - omental, donor2	11329-117E6	110.86	0.87	4.80	3.06	3.93	1.31	0.87	1.75
Preadipocyte - omental, donor3	11403-118D8	122.62	4.30	6.02	2.86	6.88	3.01	2.15	3.01
Preadipocyte - perirenal, donor1	11469-119C2	113.19	6.89	4.92	1.97	1.97	3.94	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	228.19	0.92	1.54	6.76	8.29	0.00	1.84	3.69
Preadipocyte - subcutaneous, donor2	11356-117H6	184.16	26.03	26.21	5.84	2.12	12.57	2.48	1.95
Preadipocyte - subcutaneous, donor3	11428-118G6	138.27	12.60	9.37	3.92	7.32	4.43	1.02	1.53
Preadipocyte - visceral, donor1	11280-116I2	129.94	3.54	5.12	3.17	3.54	2.24	1.02	2.79
Preadipocyte - visceral, donor2	11357-117H7	134.83	20.71	28.99	6.44	5.52	17.03	3.22	5.52
Preadipocyte - visceral, donor3	11429-118G7	140.44	16.20	10.55	4.49	3.55	6.16	1.88	1.67
Prostate Epithelial Cells (polarized), donor1	11253-116F2	83.42	5.88	5.43	6.34	9.05	1.96	1.36	0.75
Prostate Epithelial Cells, donor2	11331-117E8	102.51	11.92	13.00	12.32	13.27	7.18	6.77	2.30
Prostate Epithelial Cells, donor3	11404-118D9	88.86	5.57	7.29	7.04	6.37	4.04	2.08	1.29
Prostate Stromal Cells, donor1	11254-116F3	131.56	5.47	5.35	2.85	2.39	2.39	1.03	2.39
Prostate Stromal Cells, donor2	11332-117E9	138.06	16.67	15.06	5.74	4.66	7.35	3.59	1.97
Prostate Stromal Cells, donor3	11405-118E1	116.79	9.59	5.53	6.15	6.36	4.07	4.80	1.46
Renal Cortical Epithelial Cells, donor1	11516-119H4	173.37	2.19	1.82	1.46	1.46	0.00	1.46	3.65
Renal Cortical Epithelial Cells, donor2	11596-120H3	121.64	5.48	3.33	2.29	1.87	1.39	1.73	1.52
Renal Epithelial Cells, donor1	11517-119H5	326.15	6.09	2.03	2.54	2.54	0.51	1.52	3.04
Renal Epithelial Cells, donor2	11597-120H4	216.24	4.98	4.27	1.42	1.42	2.85	0.00	4.98
Renal Epithelial Cells, donor3	11678-122H4	103.64	4.55	3.81	1.80	1.16	0.95	0.85	2.01
Renal Glomerular Endothelial Cells, donor1	11514-119H2	202.21	10.21	4.09	8.17	2.72	6.13	2.72	2.04
Renal Glomerular Endothelial Cells, donor2	11594-120H1	204.71	6.47	4.31	6.47	2.29	3.50	4.04	1.75
Renal Glomerular Endothelial Cells, donor3	11675-122H1	152.30	4.88	3.77	0.89	0.22	1.78	2.22	2.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	246.88	4.66	11.31	8.65	7.32	8.65	3.99	3.99
Renal Mesangial Cells, donor1	11518-119H6	193.24	3.52	2.20	2.42	1.98	0.88	1.76	1.98
Renal Mesangial Cells, donor2	11598-120H5	154.24	2.51	5.64	2.51	1.25	1.88	1.88	0.63
Renal Mesangial Cells, donor3	11679-122H5	184.48	2.77	1.94	4.99	3.33	2.77	3.05	1.66
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	201.85	1.07	2.68	0.81	1.34	1.61	0.54	1.61
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	136.21	3.80	2.95	2.53	3.37	2.53	1.69	1.69
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	218.11	6.17	5.21	5.21	1.54	2.31	1.93	2.51
Retinal Pigment Epithelial Cells, donor0	11215-116A9	128.34	4.93	0.78	2.07	0.78	0.26	1.04	2.33
Retinal Pigment Epithelial Cells, donor1	11528-119I7	113.70	1.42	2.84	1.14	1.99	0.28	1.14	1.99
Retinal Pigment Epithelial Cells, donor2	11608-120I6	199.65	3.09	6.17	4.12	2.06	2.06	1.03	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	71.76	2.26	3.26	3.76	3.26	1.76	0.75	1.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	97.96	2.54	2.27	4.01	4.41	0.67	0.94	1.07
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	81.30	0.89	3.57	3.57	4.47	1.79	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	128.24	19.26	15.96	22.01	20.91	9.36	2.75	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	124.71	2.90	3.48	3.48	4.64	0.58	1.74	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	229.75	5.59	8.19	2.99	2.34	1.95	2.08	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	225.03	19.76	12.61	6.06	2.58	6.36	2.58	2.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	216.83	3.90	2.90	4.02	2.45	1.67	1.67	1.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	368.28	11.66	6.45	7.19	2.73	2.48	2.60	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	252.55	30.07	16.43	7.69	5.01	6.99	4.55	3.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	263.26	13.17	7.17	13.17	4.39	5.55	3.47	3.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	239.73	6.85	5.48	3.70	1.78	2.33	1.23	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	237.50	22.54	18.61	7.11	3.48	7.26	4.24	2.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	185.82	2.33	1.25	3.94	1.43	0.54	0.72	2.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	265.25	7.32	7.75	5.74	3.30	3.44	1.86	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	261.20	26.94	11.59	6.76	3.33	5.90	3.11	2.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	258.89	11.06	5.09	9.29	2.43	3.76	2.66	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	209.91	4.59	6.50	2.10	1.15	1.91	1.91	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	242.41	15.09	6.99	5.40	2.24	3.73	2.14	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	211.02	3.76	2.82	9.02	3.19	3.01	2.63	3.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	244.05	5.31	3.32	2.65	1.73	2.26	0.80	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	256.40	22.00	11.00	8.37	3.02	6.13	4.09	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	254.74	6.49	4.20	11.84	3.06	3.44	1.72	2.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	262.39	7.80	5.13	2.56	2.35	2.56	1.50	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	214.99	28.31	14.58	9.25	6.45	7.01	2.80	4.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	245.58	9.23	6.15	8.20	3.59	3.25	2.56	2.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	237.58	5.11	3.65	3.28	0.73	1.46	0.55	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	254.09	27.47	15.33	5.27	2.58	7.36	2.82	3.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	278.98	9.67	5.10	11.55	3.36	3.49	2.42	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	279.27	11.09	8.49	4.95	3.07	4.48	1.18	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	247.42	28.37	17.86	6.15	3.37	8.53	3.37	3.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	260.74	10.76	8.89	13.56	5.14	4.91	3.04	2.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	281.38	7.05	4.98	4.15	3.94	3.73	3.32	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	204.62	44.91	26.10	7.96	5.31	10.40	3.76	3.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	248.57	8.36	3.55	9.40	1.88	1.88	1.46	2.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	295.82	10.36	6.19	4.44	2.15	4.85	1.75	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	245.05	7.49	3.92	2.90	2.21	1.70	1.36	2.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	235.40	7.90	3.66	8.48	1.54	2.31	2.70	3.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	301.92	12.38	12.04	4.47	4.13	4.47	1.89	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	241.28	7.68	5.08	3.98	1.78	2.47	0.82	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	238.21	17.57	8.21	10.01	3.28	3.28	4.43	5.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	270.81	7.33	5.79	4.26	2.73	3.58	1.53	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	332.76	9.77	2.66	18.20	3.11	4.44	3.11	3.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	267.88	5.33	3.47	6.13	1.87	1.87	1.60	2.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	258.01	7.19	5.12	5.39	3.87	3.18	1.24	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	278.58	11.43	4.52	15.48	3.10	5.00	1.90	3.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	299.69	7.05	3.63	7.66	3.43	3.43	2.82	3.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	267.36	9.70	10.83	9.13	6.78	6.31	3.01	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	301.50	15.02	10.13	30.39	6.99	3.49	4.54	5.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	249.02	5.44	3.02	6.04	3.93	0.30	0.60	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	280.14	10.40	10.77	21.05	16.52	5.75	3.06	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	192.86	2.04	2.18	5.97	3.78	1.16	1.16	3.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	222.08	6.69	6.69	10.34	7.30	1.83	1.83	3.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	254.08	4.82	6.03	10.85	9.04	1.81	0.90	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	272.56	13.35	16.29	58.81	23.75	6.11	7.69	2.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	254.61	13.18	10.48	14.68	6.59	4.79	3.89	3.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	239.34	7.67	13.11	36.01	31.88	5.08	3.90	2.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	248.88	2.13	11.95	68.94	83.03	1.92	6.40	7.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	217.55	0.00	5.41	13.22	19.23	1.80	1.80	4.81
Schwann Cells, donor1	11498-119F4	324.99	11.47	4.51	5.08	1.69	2.44	1.88	3.20
Schwann Cells, donor2	11578-120F3	227.96	3.40	6.80	0.00	0.00	10.21	0.00	0.00
Schwann Cells, donor3	11659-122F3	222.15	10.30	8.54	2.85	1.53	3.94	1.10	2.63
Sebocyte, donor1	11220-116B5	374.67	3.83	4.38	10.41	3.29	3.29	4.38	7.12
Sebocyte, donor2	11301-117B5	189.80	11.03	13.79	6.89	5.51	8.73	3.68	1.84
Sebocyte, donor3	11378-118B1	196.84	8.86	8.24	8.86	2.68	5.98	2.47	2.89
Sertoli Cells, donor1	11255-116F4	225.30	4.97	1.66	4.97	9.94	3.31	1.66	6.63
Sertoli Cells, donor2	11333-117F1	90.38	8.47	28.24	11.30	8.47	11.30	5.65	14.12
Skeletal Muscle Cells, donor1	11281-116I3	106.10	2.99	3.08	3.34	9.33	1.94	1.32	1.67
Skeletal Muscle Cells, donor2	11358-117H8	143.85	5.06	0.00	14.46	18.79	2.17	2.17	2.17
Skeletal Muscle Cells, donor3	11430-118G8	585.23	11.70	10.87	23.41	10.87	4.18	7.52	5.85
Skeletal Muscle Cells, donor4	11451-119A2	147.83	5.97	3.77	2.83	1.57	1.41	2.20	0.94
Skeletal Muscle Cells, donor5	11455-119A6	130.36	6.09	2.82	2.38	1.78	2.82	2.23	0.74
Skeletal Muscle Cells, donor6	11459-119B1	190.22	9.08	4.31	2.92	1.08	2.92	2.92	1.23
Skeletal Muscle Satellite Cells, donor1	11240-116D7	114.29	3.78	1.89	2.77	3.28	1.51	1.39	2.02
Skeletal Muscle Satellite Cells, donor2	11321-117D7	134.98	7.71	6.28	4.00	1.71	3.85	2.43	1.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	200.30	6.05	4.66	4.96	2.18	2.98	2.38	2.48
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	74.06	2.19	1.35	2.27	2.19	0.67	0.59	1.01
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	354.64	6.51	3.62	9.41	5.07	0.72	4.34	5.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	192.50	4.27	2.61	5.50	3.72	1.65	4.27	2.34
Skin - palm, donor1	10286-104F7	94.01	0.00	0.00	0.00	2.69	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	74.24	8.79	6.63	3.03	4.04	2.02	1.59	1.59
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	49.07	3.27	10.63	0.00	1.64	2.45	0.00	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	81.53	13.37	7.40	3.64	3.76	3.38	1.43	1.56
Small Airway Epithelial Cells, donor1	11256-116F5	76.73	5.28	6.26	5.00	7.78	2.36	1.81	2.64
Small Airway Epithelial Cells, donor2	11334-117F2	103.38	6.05	4.22	1.97	5.20	1.83	1.97	2.25
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	101.07	0.42	1.27	0.85	1.06	1.48	0.63	1.27
Small Airway Epithelial Cells, donor3	11406-118E2	104.56	4.20	3.30	3.07	2.70	1.50	1.42	2.17
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	231.44	16.05	20.06	8.02	11.42	6.79	3.70	2.78
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	126.28	6.00	7.34	1.56	1.78	1.78	1.33	1.33
Smooth Muscle Cells - Aortic, donor0	11210-116A4	288.62	1.76	2.35	7.05	3.53	2.35	2.35	4.11
Smooth Muscle Cells - Aortic, donor1	11283-116I5	165.30	2.21	5.30	3.09	3.31	0.22	2.65	2.21
Smooth Muscle Cells - Aortic, donor2	11360-117I1	279.19	2.36	2.76	3.54	9.45	1.97	3.15	4.73
Smooth Muscle Cells - Aortic, donor3	11432-118H1	302.07	0.00	0.77	2.32	6.95	1.55	2.32	6.18
Smooth Muscle Cells - Bladder, donor1	11519-119H7	62.05	5.00	3.00	3.00	3.00	2.00	2.00	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	260.43	2.66	4.13	11.98	17.57	0.53	3.59	5.46
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	134.10	14.85	10.64	4.43	2.66	5.54	2.44	1.33
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	74.77	1.02	1.02	1.79	2.69	0.26	0.51	1.41
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	106.14	1.63	0.98	1.63	0.65	0.33	0.65	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	124.92	1.18	1.48	1.48	1.18	1.18	1.18	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	126.85	4.13	3.13	3.84	2.28	1.99	1.57	2.85
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	271.99	3.25	2.60	3.09	2.60	1.63	1.95	3.09
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	136.39	4.26	1.83	1.22	1.52	0.91	1.22	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	253.32	1.77	2.78	6.57	13.13	1.01	4.80	5.30
Smooth Muscle Cells - Carotid, donor2	11362-117I3	312.16	6.12	0.00	0.00	0.00	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	367.64	9.06	7.63	18.12	12.40	2.86	10.01	4.77
Smooth Muscle Cells - Colonic, donor1	11239-116D6	86.86	3.54	1.47	2.21	1.77	1.03	0.59	1.33
Smooth Muscle Cells - Colonic, donor2	11320-117D6	105.47	8.61	6.46	4.09	2.37	3.66	3.23	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	136.45	5.25	5.46	3.04	1.89	1.78	2.31	2.41
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	292.96	2.47	1.86	5.41	10.98	2.17	3.25	4.95
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	254.38	2.16	3.23	7.55	3.23	2.16	4.31	6.47
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	157.50	2.39	2.99	5.38	3.29	0.60	2.09	1.49
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	232.49	3.07	1.71	3.41	1.02	1.37	0.00	2.73
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	74.92	1.96	1.73	1.49	0.94	0.71	0.79	0.86
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	146.94	6.14	21.84	14.39	20.53	8.55	7.85	4.33
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	166.11	22.53	8.19	5.46	5.46	7.96	1.37	2.50
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	260.85	9.06	5.43	14.49	12.68	4.83	1.21	3.62
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	248.50	6.89	2.38	4.50	2.12	1.32	1.59	3.71
Smooth Muscle Cells - Prostate, donor1	11257-116F6	111.99	2.80	3.46	2.66	5.06	1.46	1.33	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	122.09	10.89	10.27	9.02	7.51	7.76	4.63	1.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	100.70	2.03	1.27	2.54	5.07	0.76	1.01	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	218.77	4.22	3.77	6.18	7.69	1.36	3.17	3.47
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	197.29	7.50	6.00	12.00	9.00	2.25	4.50	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	127.93	1.29	18.09	1.29	5.17	1.29	18.09	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	280.90	1.40	3.72	10.23	15.81	0.93	6.51	4.65
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	204.48	22.21	20.70	7.57	6.06	9.59	2.52	2.02
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	198.07	4.70	8.78	12.85	14.10	4.39	2.51	1.57
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	121.24	4.42	2.65	1.18	1.47	0.59	1.47	2.06
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	228.93	1.75	0.67	1.42	0.67	0.25	0.33	1.75
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	101.37	6.07	2.80	2.80	1.87	0.93	1.87	2.80
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	248.12	2.16	1.73	7.05	14.82	1.01	2.16	5.32
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	437.76	11.47	6.63	15.04	7.14	3.31	8.41	11.22
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	284.49	5.64	3.38	9.21	6.77	2.26	4.51	3.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	184.46	3.21	2.10	1.40	0.70	1.12	0.84	1.26
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	163.64	2.51	0.67	1.34	0.75	0.84	0.84	0.75
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	136.66	2.86	4.76	2.38	0.48	0.95	0.48	2.86
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	310.23	2.94	1.47	14.19	12.48	0.98	4.16	6.61
Smooth Muscle Cells - Uterine, donor1	11258-116F7	117.10	3.09	3.09	5.52	4.86	2.43	2.21	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	183.74	8.19	5.27	3.51	2.93	3.80	1.76	3.22
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	49.76	3.11	4.86	1.75	4.08	1.94	1.17	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	78.28	6.35	14.02	3.70	4.50	4.50	2.91	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	39.43	6.32	17.11	5.95	11.53	6.70	4.46	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	71.15	8.26	11.50	5.03	5.03	2.16	1.44	2.16
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	76.65	1.42	5.39	1.70	3.12	1.99	1.70	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	90.59	13.39	14.57	3.94	2.36	3.94	2.36	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	53.58	4.83	10.41	4.83	3.56	3.56	0.76	1.52
Smooth muscle cells - airway, control, donor2	11967-126D5	43.93	2.00	6.79	2.80	7.19	1.60	1.20	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	39.71	1.25	7.11	3.34	8.78	1.67	2.51	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	45.38	5.96	5.04	0.46	4.13	0.46	0.00	0.00
Synoviocyte, donor1	11291-117A4	108.57	6.90	7.91	4.04	6.23	2.36	0.84	1.51
Synoviocyte, donor2	11368-117I9	115.66	8.21	5.03	3.02	4.36	5.03	2.01	1.51
Synoviocyte, donor3	11440-118H9	84.00	6.26	3.80	1.12	2.23	2.23	1.79	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	346.25	3.57	4.65	2.14	2.14	1.07	2.14	3.57
Trabecular Meshwork Cells, donor2	11612-122A1	176.40	3.96	0.00	5.95	0.00	0.00	1.98	3.96
Trabecular Meshwork Cells, donor3	11693-123A1	256.09	7.41	3.01	5.56	2.08	1.85	1.85	3.24
Tracheal Epithelial Cells, donor1	11292-117A5	115.70	0.57	0.93	3.15	3.66	0.57	1.08	2.15
Tracheal Epithelial Cells, donor2	11369-118A1	234.64	2.32	2.32	8.50	4.64	3.48	3.09	2.71
Tracheal Epithelial Cells, donor3	11441-118I1	230.21	5.15	4.58	6.30	10.88	1.72	3.44	5.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	105.80	1.85	1.97	5.66	5.17	1.11	0.62	1.11
Urethra, donor2	10319-105A4	62.94	1.80	0.00	1.80	1.80	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	155.15	3.45	3.98	1.59	1.86	1.06	1.33	0.80
Urothelial Cells, donor2	11600-120H7	114.16	4.41	4.01	2.00	2.80	2.40	2.00	1.20
Urothelial Cells, donor3	11681-122H7	140.73	4.35	2.52	3.21	1.83	2.06	1.15	2.06
Urothelial cells, donor0	11216-116B1	120.81	3.12	0.89	2.01	1.11	0.22	0.89	1.34
Whole blood (ribopure), donor090309, donation1	12179-129A1	117.45	0.89	4.45	2.67	0.89	2.67	2.67	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	90.07	1.43	5.72	4.29	0.00	0.00	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	79.40	6.85	5.48	1.37	0.68	2.05	1.37	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	99.86	1.38	0.34	0.34	0.00	0.34	0.00	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	79.60	2.32	3.49	1.74	0.58	0.58	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	115.58	2.08	2.08	1.04	0.00	1.04	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	102.79	2.75	0.00	2.75	0.92	0.92	0.00	2.75
Whole blood (ribopure), donor090612, donation3	12184-129A6	117.76	7.30	4.56	3.65	0.00	4.56	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	81.05	2.96	1.73	0.74	0.62	1.48	1.36	1.73
Wilms' tumor cell line:HFWT	10597-108E3	40.48	0.00	0.00	0.88	0.00	0.00	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	117.87	4.19	1.12	0.56	0.00	1.96	0.56	1.12
achilles tendon, donor2	10292-104G4	84.73	0.00	2.07	2.07	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	140.48	2.04	3.31	1.53	1.53	1.53	1.27	1.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	155.56	2.55	0.93	0.93	0.23	0.93	0.23	1.63
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	150.52	1.07	0.95	2.14	0.83	0.59	0.47	0.71
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	147.49	2.18	1.90	1.09	1.63	1.36	0.54	1.63
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	140.26	5.62	4.50	2.25	1.97	3.65	1.97	1.97
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	143.38	0.42	2.11	2.54	0.42	1.06	0.85	1.27
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	116.51	2.18	3.81	2.18	1.91	1.91	1.91	1.63
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	150.70	2.64	4.41	2.64	1.32	2.20	1.32	2.20
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	134.76	2.86	5.31	1.23	2.86	0.82	1.23	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	208.13	1.94	3.88	1.55	1.94	1.55	1.55	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	192.28	9.38	7.36	4.42	2.02	5.52	2.58	3.68
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	124.82	0.00	0.00	7.80	3.90	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	128.51	3.95	3.02	1.63	0.23	0.70	1.86	1.16
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	148.35	6.73	5.44	3.62	1.04	2.59	2.07	1.81
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	123.91	4.97	7.31	1.46	0.88	2.92	1.75	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	81.33	2.32	1.39	0.93	0.93	0.93	0.46	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	72.79	3.29	4.11	1.23	1.23	0.41	0.41	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	117.25	1.84	3.68	1.53	0.61	0.61	0.31	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	139.53	4.69	6.83	2.13	0.43	2.13	0.00	2.13
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	134.97	1.52	1.21	2.73	1.21	0.61	0.30	2.12
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	151.16	3.37	3.85	2.17	1.44	1.20	0.48	1.68
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	118.50	6.90	7.13	2.00	1.11	3.12	2.23	1.78
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	95.06	1.33	1.67	0.67	0.33	1.00	0.67	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	40.88	0.00	0.00	0.00	3.72	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	111.49	3.01	4.14	4.14	0.38	1.88	0.38	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	99.87	1.31	2.18	0.44	2.18	0.00	0.87	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	52.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	71.59	0.94	0.47	0.47	0.47	0.24	0.94	0.47
adipose tissue, adult, pool1	10010-101C1	126.58	3.41	3.57	10.24	10.24	1.24	2.02	2.17
adipose, donor1	10184-103D4	36.94	2.93	1.17	8.21	6.45	0.00	1.17	0.59
adipose, donor2	10185-103D5	37.31	2.84	2.43	4.87	7.30	1.22	0.00	0.00
adipose, donor3	10186-103D6	55.00	2.45	3.27	4.08	10.62	1.09	0.27	0.27
adipose, donor4	10187-103D7	86.68	4.33	4.33	3.47	9.53	2.60	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	127.99	1.58	0.32	1.10	1.26	0.16	0.95	3.00
adrenal gland, adult, pool1	10081-102A9	94.58	0.00	3.64	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	144.21	1.60	0.67	3.20	2.40	0.80	0.53	0.93
alveolar cell carcinoma cell line:SW 1573	10708-109H6	116.12	3.93	1.43	2.86	2.50	3.57	1.43	1.43
amniotic membrane cells, donor1	12235-129G3	144.21	2.78	2.55	1.16	0.46	0.23	1.62	1.62
amniotic membrane cells, donor2	12236-129G4	104.14	2.37	1.35	2.70	2.70	0.68	0.68	0.68
amniotic membrane cells, donor3	12237-129G5	133.16	1.77	1.77	0.88	1.47	0.00	1.77	0.88
amygdala - adult, donor10196	10167-103B5	128.07	2.37	2.37	0.00	7.11	1.19	0.00	2.37
amygdala, adult, donor10252	10151-102I7	137.68	4.46	3.85	1.82	0.81	1.62	1.01	0.00
amygdala, newborn, donor10223	10360-105E9	64.88	1.61	3.23	1.61	0.32	2.58	0.00	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	92.70	0.76	1.15	2.80	2.67	0.51	0.89	0.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	127.96	3.75	2.21	0.66	2.43	1.10	1.76	2.65
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	66.81	0.67	1.00	1.00	0.67	0.67	1.00	0.33
aorta, adult, pool1	10052-101G7	113.95	2.75	1.77	1.96	0.78	1.37	1.37	1.77
appendix, adult	10189-103D9	134.29	1.94	4.66	11.64	6.99	1.94	2.72	2.33
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	75.32	1.72	1.03	0.69	1.72	2.06	0.69	0.00
artery, adult	10190-103E1	69.29	5.43	2.72	0.00	1.36	2.72	4.08	0.00
astrocytoma cell line:TM-31	10425-106D2	79.53	1.30	1.16	1.16	0.58	0.43	0.29	0.72
b cell line:RPMI1788	10427-106D4	111.53	1.19	1.19	1.78	1.19	0.45	0.74	1.04
basal cell carcinoma cell line:TE 354.T	10702-109G9	212.80	3.33	5.55	4.16	4.44	1.94	0.83	2.77
bile duct carcinoma cell line:HuCCT1	10432-106D9	159.27	2.98	1.79	2.68	2.28	0.30	1.09	2.08
bile duct carcinoma cell line:TFK-1	10496-107C1	46.70	0.50	0.50	0.00	0.33	0.67	0.67	0.84
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	69.90	0.56	0.56	0.56	0.56	1.12	0.56	0.00
bladder, adult, pool1	10011-101C2	102.99	1.85	3.15	4.02	3.59	0.54	1.41	0.76
blood, adult, pool1	10053-101G8	79.73	2.21	0.00	4.43	8.86	2.21	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	125.88	0.00	2.57	0.00	2.57	1.71	0.00	0.00
bone marrow, adult	10192-103E3	98.52	10.12	6.07	10.12	4.72	3.37	1.35	2.70
brain, adult, donor1	10084-102B3	105.58	2.05	2.05	3.08	2.05	0.00	1.03	1.03
brain, adult, pool1	10012-101C3	133.74	3.12	2.34	4.90	2.34	1.22	0.89	1.11
brain, fetal, pool1	10085-102B4	130.90	2.67	2.67	2.67	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	85.23	1.98	2.64	0.66	0.33	0.99	0.33	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	100.36	1.62	1.12	1.00	0.62	0.37	0.00	1.62
breast, adult, donor1	10080-102A8	114.28	1.89	0.00	7.58	7.58	0.00	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	90.20	2.92	2.29	0.51	1.02	1.14	0.89	0.89
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	126.16	3.71	1.86	0.00	0.93	1.55	0.93	1.55
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	55.48	6.45	4.14	2.99	0.46	3.45	0.69	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	50.11	1.21	1.69	0.48	1.21	0.97	0.48	0.48
carcinoid cell line:NCI-H1770	10703-109H1	101.56	2.82	2.35	1.41	0.94	0.00	1.88	0.47
carcinoid cell line:NCI-H727	10735-110B6	82.14	1.64	0.55	0.77	0.98	0.22	0.33	1.09
carcinoid cell line:SK-PN-DW	10719-109I8	77.64	2.54	2.85	1.27	2.22	1.27	0.63	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	103.01	8.25	4.53	3.73	1.60	2.66	1.60	0.80
caudate nucleus - adult, donor10196	10177-103C6	116.28	1.15	2.30	2.30	0.00	4.61	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	156.78	4.35	2.84	2.51	1.17	2.18	1.17	1.34
caudate nucleus, adult, donor10258	10379-105H1	119.21	3.82	3.06	3.82	0.76	4.58	1.53	0.76
caudate nucleus, newborn, donor10223	10354-105E3	78.01	2.93	4.03	0.37	1.83	1.46	0.73	0.00
cerebellum - adult, donor10196	10173-103C2	52.44	0.00	0.00	0.00	2.91	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	89.25	2.56	1.92	4.27	0.85	1.49	0.21	0.64
cerebellum, adult, pool1	10083-102B2	39.67	0.69	0.69	1.03	0.69	0.34	1.03	0.34
cerebellum, newborn, donor10223	10357-105E6	49.82	0.83	0.83	0.83	0.00	2.49	0.83	0.00
cerebral meninges, adult	10188-103D8	107.66	1.26	1.51	4.79	1.26	1.01	1.26	0.76
cerebrospinal fluid, donor2	10294-104G6	47.51	0.73	2.92	0.00	0.00	1.46	0.73	2.19
cervical cancer cell line:D98-AH2	10552-107I3	83.11	0.72	0.86	1.01	1.44	0.58	0.72	1.29
cervical cancer cell line:ME-180	10553-107I4	98.27	1.33	0.66	0.33	1.99	0.50	0.00	0.66
cervix, adult, pool1	10013-101C4	113.70	3.78	3.25	4.20	5.35	0.73	1.36	1.36
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	96.14	2.23	2.37	1.25	2.65	0.14	1.25	1.25
chondrosarcoma cell line:SW 1353	10700-109G7	39.19	0.00	0.00	0.00	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	52.69	1.86	1.24	3.23	3.73	0.99	0.37	0.50
choriocarcinoma cell line:SCH	10785-110H2	50.89	1.36	0.25	0.37	0.49	0.12	0.49	0.62
choriocarcinoma cell line:T3M-3	10618-108G6	85.62	0.24	0.71	0.95	1.42	0.24	0.24	0.47
chorionic membrane cells, donor1	12238-129G6	99.44	2.85	0.85	1.99	2.28	0.00	0.57	1.14
chorionic membrane cells, donor2	12239-129G7	153.12	2.88	4.87	8.95	11.43	1.89	2.49	2.49
chorionic membrane cells, donor3	12240-129G8	115.94	4.40	4.40	5.49	4.40	0.55	1.10	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	112.09	5.05	5.05	4.04	3.03	3.03	4.04	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	121.41	1.73	1.54	1.34	0.96	0.19	1.73	1.92
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	68.42	1.06	0.42	0.00	0.63	0.00	0.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	79.09	3.08	2.82	0.77	0.00	0.51	0.51	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	79.82	3.14	0.97	0.48	0.00	0.24	0.48	0.97
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	74.32	2.85	2.85	0.41	0.61	0.81	1.02	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	62.13	0.88	1.18	0.88	0.29	0.29	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	167.84	2.09	2.09	2.09	1.04	1.04	0.78	1.04
clear cell carcinoma cell line:JHOC-5	10638-108I8	100.58	6.63	5.03	3.43	3.20	3.66	2.74	0.91
clear cell carcinoma cell line:TEN	10636-108I6	61.25	0.52	2.43	0.69	1.04	0.17	0.52	0.52
colon carcinoma cell line:CACO-2	10513-107D9	87.31	2.20	1.65	0.37	0.92	0.18	0.37	1.28
colon carcinoma cell line:COLO-320	10420-106C6	153.93	3.42	1.90	0.76	0.38	0.76	1.52	1.14
colon, adult, donor1	10082-102B1	132.09	1.19	2.38	1.19	1.19	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	136.07	1.29	1.29	10.22	9.05	1.06	1.76	1.65
colon, fetal, donor1	10070-101I7	71.69	0.62	0.62	6.18	3.09	0.62	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	178.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	34.84	0.85	0.85	0.00	0.42	0.00	0.00	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	55.24	0.45	1.36	1.81	1.51	1.21	0.75	1.36
cord blood derived cell line:COBL-a untreated	10449-106F8	65.57	0.99	1.55	0.99	1.13	0.85	0.42	1.55
corpus callosum, adult, pool1	10042-101F6	166.62	1.55	1.44	2.10	0.66	0.55	1.22	1.11
cruciate ligament, donor2	10295-104G7	80.24	0.81	0.81	1.62	0.00	1.62	0.81	1.62
diaphragm, fetal, donor1	10069-101I6	68.22	0.00	0.00	0.00	0.80	0.00	0.00	0.00
diencephalon, adult	10193-103E4	119.51	2.40	5.76	4.32	1.44	1.92	0.72	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	144.88	15.15	10.79	4.13	0.92	5.97	2.76	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	58.21	0.77	0.51	0.51	0.77	0.00	0.51	1.03
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	56.09	1.69	1.93	0.48	1.93	0.48	0.48	1.69
ductus deferens, adult	10196-103E7	82.72	3.49	2.49	4.49	1.00	1.50	1.00	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	99.38	4.32	1.44	1.44	2.88	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	109.61	3.68	5.15	3.68	0.74	2.94	2.21	3.68
dura mater, adult, donor1	10041-101F5	195.90	2.48	1.90	3.63	2.97	1.65	0.91	1.90
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	99.49	4.00	6.00	11.10	13.32	2.89	3.33	4.66
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	152.61	2.87	6.02	7.16	5.30	2.29	2.29	4.87
embryonic pancreas cell line:1B2C6	10604-108F1	86.33	1.23	0.62	0.62	1.23	0.62	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	70.23	2.72	1.21	1.21	0.61	0.91	1.21	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	69.47	1.23	0.62	0.31	0.93	0.00	0.31	0.31
embryonic pancreas cell line:2C6	10603-108E9	65.67	0.00	2.63	0.00	0.00	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	21.79	0.00	0.67	0.34	0.34	0.67	0.00	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	114.36	1.99	2.54	1.99	0.91	0.18	0.72	1.81
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	97.77	8.52	6.91	3.06	1.77	4.18	2.25	2.73
epidermoid carcinoma cell line:A431	10426-106D3	77.03	1.11	1.00	1.11	1.45	0.33	0.44	1.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	198.85	2.64	1.43	2.75	1.10	1.65	0.55	2.31
epididymis, adult	10197-103E8	93.35	3.98	3.77	21.14	4.81	2.51	1.67	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	52.34	0.71	0.53	1.42	0.71	0.53	0.35	1.06
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	25.17	0.39	0.00	0.00	0.00	0.00	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	152.80	6.81	5.24	2.49	1.57	2.88	1.31	1.83
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	145.66	6.00	3.64	1.28	0.69	1.77	0.89	1.48
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	164.57	9.63	5.27	2.35	1.34	3.58	1.46	1.68
esophagus, adult, pool1	10015-101C6	105.75	2.44	2.76	5.63	5.20	1.49	2.02	1.27
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	95.93	1.75	1.25	1.25	3.13	0.00	1.00	3.63
eye - muscle inferior rectus, donor1	10272-104E2	101.41	2.41	2.41	2.41	0.00	0.00	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	35.77	0.00	0.00	2.10	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	58.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	55.03	0.00	0.00	0.00	1.15	1.15	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	61.21	1.46	2.91	2.91	4.37	0.00	0.00	1.46
eye, fetal, donor1	10054-101G9	72.97	1.78	1.02	1.78	0.00	1.27	0.51	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	81.81	2.05	1.41	1.28	0.90	0.77	0.26	1.15
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	111.11	2.85	2.37	2.14	1.66	0.71	0.71	1.19
frontal lobe, adult, pool1	10040-101F4	128.54	1.31	1.03	0.84	0.56	0.47	0.47	0.66
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	74.76	2.70	0.90	2.10	1.50	0.30	0.90	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	80.01	0.73	1.46	0.46	0.37	0.37	0.64	0.55
gall bladder, adult	10198-103E9	119.99	4.10	4.35	9.42	3.86	2.41	1.45	1.21
gamma delta positive T cells, donor1	11937-126A2	157.30	3.76	3.22	3.22	2.15	0.54	1.61	1.61
gamma delta positive T cells, donor2	11938-126A3	132.96	3.36	4.48	1.12	1.87	0.75	1.49	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	51.75	5.28	1.69	0.84	0.84	1.69	1.06	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	102.51	1.93	0.58	1.16	0.58	0.58	0.00	1.93
gastric cancer cell line:AZ521	10549-107H9	91.49	0.98	1.15	0.82	0.16	0.33	0.16	1.31
gastric cancer cell line:GSS	10560-108A2	144.61	4.58	1.83	4.58	1.83	0.92	0.92	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	95.04	4.57	3.66	2.74	0.69	2.51	2.28	0.91
giant cell carcinoma cell line:LU65	10487-107B1	51.98	1.03	1.72	1.15	0.80	0.57	0.34	1.03
giant cell carcinoma cell line:Lu99B	10433-106E1	107.07	1.26	1.12	0.98	0.84	0.84	1.12	0.98
glassy cell carcinoma cell line:HOKUG	10688-109F4	46.39	2.24	1.75	0.25	0.25	0.00	0.00	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	92.46	1.16	1.69	1.16	0.95	0.74	0.63	1.16
glioblastoma cell line:A172, tech_rep2	10444-106F3	101.40	0.84	0.84	0.98	0.84	0.14	0.42	1.26
glioblastoma cell line:T98G	10485-107A8	75.27	0.66	1.21	0.66	0.33	0.44	0.44	0.66
glioma cell line:GI-1	10413-106B8	70.58	2.34	2.64	2.05	3.51	0.88	0.29	0.88
globus pallidus - adult, donor10196	10175-103C4	99.86	0.00	0.73	0.73	0.00	0.73	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	156.22	4.15	4.88	2.93	2.20	2.44	0.98	1.22
globus pallidus, adult, donor10258	10367-105F7	120.49	4.11	0.00	4.11	1.37	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	54.89	3.73	1.60	2.66	2.13	2.13	1.07	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	286.32	0.00	2.45	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	87.43	10.93	10.93	0.00	0.00	10.93	10.93	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	31.36	0.00	0.00	0.00	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	78.08	3.52	2.88	0.96	0.96	0.00	0.96	0.64
hIPS +CCl2, biol_rep1	14383-156B9	48.21	1.84	3.67	0.92	1.38	0.92	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	47.56	0.46	5.49	1.83	3.20	3.20	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	38.65	0.00	3.86	0.00	1.93	1.93	0.00	0.64
hIPS, biol_rep1	14380-156B6	20.12	0.00	5.75	1.44	0.00	0.00	1.44	1.44
hIPS, biol_rep2	14381-156B7	38.41	2.74	0.69	0.00	1.37	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	80.55	0.00	3.31	0.00	2.21	1.10	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	137.35	4.02	2.87	1.44	0.29	0.57	0.86	3.45
heart - mitral valve, adult	10205-103F7	80.12	4.48	2.39	1.49	2.39	0.60	0.90	0.90
heart - pulmonic valve, adult	10206-103F8	71.91	2.61	1.05	2.09	1.31	0.00	0.52	0.78
heart - tricuspid valve, adult	10207-103F9	125.73	3.33	3.33	4.16	5.83	0.83	0.00	3.33
heart, adult, diseased post-infarction, donor1	10050-101G5	83.05	4.08	1.63	0.82	0.20	1.22	0.61	1.02
heart, adult, diseased, donor1	10051-101G6	80.48	5.96	2.98	0.85	0.43	2.55	1.70	0.43
heart, adult, pool1	10016-101C7	91.30	0.00	0.23	0.46	0.46	0.23	0.23	0.46
heart, fetal, pool1	10046-101G1	96.72	1.23	1.03	1.03	0.62	0.31	0.51	0.62
hepatic mesenchymal tumor cell line:LI90	10778-110G4	125.57	3.39	1.23	0.31	1.23	0.62	0.62	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	26.16	0.00	1.19	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	148.51	8.73	4.42	1.22	0.66	2.65	1.55	2.76
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	170.41	11.29	4.25	2.67	1.82	3.88	2.06	2.67
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	160.07	7.98	4.04	1.31	0.91	2.12	1.52	3.44
hepatoma cell line:Li-7	10484-107A7	65.28	0.89	1.33	0.56	0.44	0.67	0.67	0.67
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	92.86	0.80	0.50	0.50	0.40	0.20	0.20	0.40
hippocampus - adult, donor10196	10169-103B7	99.36	0.95	2.84	1.89	0.95	0.95	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	132.26	5.51	4.29	2.25	1.02	1.63	0.61	0.61
hippocampus, adult, donor10258	10374-105G5	69.22	1.49	1.00	0.50	1.00	0.00	1.00	0.00
hippocampus, newborn, donor10223	10363-105F3	71.20	3.17	2.11	2.11	2.47	0.00	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	64.09	9.77	8.54	4.88	6.10	7.93	1.22	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	60.28	3.53	5.11	3.34	3.93	2.16	1.77	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	51.79	5.33	6.86	5.08	4.82	2.29	1.52	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	38.34	2.26	3.38	7.33	13.53	2.82	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	49.58	8.78	8.78	6.97	14.20	3.36	2.07	2.07
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	45.17	3.04	5.31	4.93	8.73	1.52	0.76	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	45.84	1.46	4.96	8.17	13.72	2.04	1.17	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	60.97	3.23	3.88	8.19	15.30	2.15	2.37	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	45.04	1.25	4.17	7.51	13.35	0.83	0.83	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	74.12	1.66	2.37	4.74	10.66	0.95	1.42	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	78.91	6.91	6.11	7.39	15.59	1.61	1.61	1.61
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	56.56	0.00	2.02	3.37	6.06	0.00	1.35	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	52.89	5.16	4.54	2.50	3.44	2.35	0.78	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	47.16	7.37	10.81	3.93	5.40	2.46	0.49	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	29.67	3.49	8.73	0.87	1.75	2.62	0.00	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	55.36	3.63	3.63	6.68	13.75	1.15	0.38	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	61.92	3.92	2.62	6.11	10.90	0.00	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	25.99	4.00	2.50	5.50	9.50	2.00	1.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	44.08	2.45	3.01	6.41	9.80	1.32	0.94	1.13
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	41.38	3.18	4.09	6.37	11.82	1.82	0.91	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	26.63	3.13	3.13	5.64	5.01	0.63	0.94	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	62.05	5.23	3.59	6.37	9.80	1.63	1.63	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	70.84	3.48	4.06	7.26	10.74	2.61	1.16	1.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	46.63	3.59	6.58	8.07	11.36	2.39	0.90	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	54.68	5.54	5.91	3.69	6.28	3.14	1.29	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	63.62	2.28	3.42	3.99	7.42	0.86	1.71	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	58.39	3.67	4.08	7.35	7.35	2.86	2.45	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	65.84	8.10	10.21	5.28	15.49	4.22	2.11	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	47.51	3.48	6.33	6.97	14.57	1.90	0.95	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	49.93	2.42	5.14	6.36	14.22	3.93	0.91	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	62.05	2.59	2.07	2.07	16.03	2.59	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	50.48	1.33	4.65	5.98	9.96	1.99	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	49.77	1.03	2.82	3.33	7.44	3.59	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	95.61	6.90	12.27	8.44	14.32	3.83	2.56	2.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	63.61	4.54	4.54	6.82	7.57	1.51	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	63.18	5.71	9.07	6.05	13.78	3.36	1.01	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	66.66	3.38	4.83	4.35	4.35	0.24	0.24	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	37.44	7.58	6.24	4.46	7.13	2.23	1.78	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	47.81	2.93	6.83	4.88	5.37	3.41	1.46	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	59.90	4.28	4.28	5.81	13.14	0.61	0.61	1.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	91.09	3.25	3.25	26.03	9.76	0.00	6.51	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	57.25	4.30	4.96	9.93	10.92	3.97	1.32	1.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	50.90	1.09	3.28	3.83	11.49	2.19	0.55	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	43.06	2.90	2.17	3.62	15.20	1.09	1.09	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	39.50	3.56	4.63	3.20	9.25	2.49	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	64.44	3.58	4.77	3.58	1.19	3.58	3.58	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	97.10	4.33	5.42	10.70	16.52	4.06	1.49	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	51.99	3.77	3.23	4.31	9.16	1.89	0.81	1.08
immature langerhans cells, donor1	11904-125F5	115.99	1.21	1.94	1.21	0.73	0.24	1.70	0.73
immature langerhans cells, donor2	11905-125F6	87.93	3.96	2.38	1.58	2.38	0.79	0.79	0.79
insula, adult, pool1	10039-101F3	158.98	1.14	0.76	1.42	0.47	0.76	0.76	1.04
keratoacanthoma cell line:HKA-1	10791-110H8	92.34	1.30	1.30	1.30	2.28	0.33	0.98	0.00
kidney, adult, pool1	10017-101C8	132.27	3.20	3.00	4.01	3.60	1.80	1.10	2.40
kidney, fetal, pool1	10045-101F9	126.05	1.49	0.78	1.27	0.71	0.28	1.06	1.56
large cell lung carcinoma cell line:IA-LM	10509-107D5	111.06	1.14	2.13	0.99	1.14	0.14	0.28	1.70
large cell lung carcinoma cell line:NCI-H460	10839-111E2	98.70	3.73	4.01	4.01	3.73	1.24	1.52	1.52
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	66.98	0.92	0.92	0.18	0.55	0.18	0.18	0.37
left atrium, adult, donor1	10079-102A7	45.77	1.09	1.63	2.72	1.63	1.09	0.00	0.00
left ventricle, adult, donor1	10078-102A6	64.22	1.52	1.01	2.53	2.02	0.51	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	67.31	1.09	0.00	0.00	0.27	0.27	0.27	1.92
leiomyoma cell line:10964C	10569-108B2	125.38	20.84	15.09	11.50	10.42	7.18	4.67	2.16
leiomyoma cell line:15242A	10570-108B3	114.67	10.33	10.33	5.98	9.78	6.52	1.63	2.72
leiomyoma cell line:15425	10571-108B4	148.85	26.47	17.73	10.20	8.01	10.44	4.86	2.67
leiomyosarcoma cell line:Hs 5.T	10722-110A2	63.49	6.35	6.35	0.00	6.35	0.00	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	76.33	2.09	1.05	1.05	5.23	0.00	0.00	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	196.21	3.31	2.36	1.42	1.42	0.83	0.94	1.77
liposarcoma cell line:KMLS-1	10782-110G8	118.56	3.75	2.97	1.72	1.25	2.19	1.25	0.94
liposarcoma cell line:SW 872	10726-110A6	88.21	1.58	0.85	1.10	0.85	0.49	0.24	1.10
liver, adult, pool1	10018-101C9	132.40	2.43	1.62	15.56	16.69	1.94	0.81	1.46
liver, fetal, pool1	10086-102B5	55.50	0.00	0.00	0.00	0.94	0.94	1.88	2.82
locus coeruleus - adult, donor10196	10182-103D2	74.52	1.31	1.31	1.31	1.17	0.44	0.58	0.73
locus coeruleus, adult, donor10252	10165-103B3	129.92	4.61	2.21	2.58	0.55	1.85	0.74	1.11
locus coeruleus, adult, donor10258	10375-105G6	87.46	7.62	5.08	3.10	2.54	2.26	2.26	1.97
locus coeruleus, newborn, donor10223	10362-105F2	69.40	5.05	9.67	10.94	7.15	6.31	0.00	1.68
lung adenocarcinoma cell line:A549	10499-107C4	26.85	0.28	0.00	0.28	0.42	0.00	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	43.43	0.00	0.00	0.00	2.07	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	73.03	1.19	2.11	0.92	1.19	0.26	0.66	1.05
lung, adult, pool1	10019-101D1	134.07	1.89	1.89	6.50	7.21	1.06	1.54	1.89
lung, fetal, donor1	10068-101I5	138.42	0.86	3.14	2.28	3.14	0.29	1.14	0.86
lung, right lower lobe, adult, donor1	10075-102A3	121.43	3.67	2.75	15.12	5.04	2.29	0.92	0.46
lymph node, adult, donor1	10077-102A5	140.59	4.26	6.63	3.79	4.73	4.73	0.95	2.37
lymphangiectasia cell line:DS-1	10727-110A7	88.33	1.75	1.10	0.44	0.88	0.88	0.22	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	157.11	1.51	3.62	2.11	0.91	1.81	0.91	1.21
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	116.38	1.70	1.70	3.40	3.40	0.00	0.00	1.70
mature adipocyte, donor1	12231-129F8	118.99	0.00	0.00	3.11	1.33	0.44	0.00	0.44
mature adipocyte, donor2	12232-129F9	97.75	0.42	1.87	1.87	1.25	0.42	0.21	0.21
mature adipocyte, donor3	12233-129G1	92.22	0.47	0.47	0.95	1.42	0.24	0.00	0.71
mature adipocyte, donor4	12234-129G2	81.86	1.05	1.05	3.42	1.84	0.00	0.53	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	58.85	0.71	0.48	0.48	1.67	0.24	1.91	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	78.96	1.13	2.26	0.00	1.13	1.13	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	109.42	2.57	3.13	0.37	0.55	1.29	0.92	1.47
medial frontal gyrus, adult, donor10258	10368-105F8	57.82	3.49	3.81	0.32	1.27	1.27	0.64	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	72.93	10.24	6.82	2.13	2.13	2.99	2.56	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	98.72	18.73	11.31	1.69	2.70	6.58	1.35	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	117.57	1.70	1.91	1.70	0.64	1.06	0.21	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	53.94	1.93	5.78	0.00	0.00	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	129.18	0.00	0.00	14.35	0.00	0.00	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	93.32	2.51	3.23	2.87	1.08	1.79	1.08	0.36
medulla oblongata - adult, donor10196	10174-103C3	77.88	0.65	1.95	0.00	0.65	1.30	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	117.34	2.79	2.94	1.86	1.39	0.62	0.77	1.08
medulla oblongata, adult, pool1	10038-101F2	134.85	1.39	0.73	1.55	0.65	0.57	0.41	0.98
medulla oblongata, newborn, donor10223	10361-105F1	54.85	4.17	3.82	1.74	0.35	0.69	0.35	1.39
medulloblastoma cell line:D283 Med	10838-111E1	185.99	9.96	8.41	4.43	1.99	2.66	1.99	0.89
medulloblastoma cell line:ONS-76	10759-110E3	164.95	2.20	0.98	1.35	1.10	0.24	1.35	1.96
melanoma cell line:COLO 679	10514-107E1	170.63	2.87	5.03	4.31	11.36	1.01	1.58	2.73
melanoma cell line:G-361	10465-106H6	93.11	2.17	5.43	9.50	15.20	3.26	3.26	0.81
meningioma cell line:HKBMM	10691-109F7	74.17	5.25	4.70	2.35	2.53	2.71	1.45	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	228.22	22.91	20.27	10.57	1.76	7.05	2.64	7.05
merkel cell carcinoma cell line:MS-1	10844-111E7	211.27	4.15	5.18	4.41	1.30	2.07	2.85	2.07
mesenchymal precursor cell - adipose, donor1	11747-123G1	144.53	4.91	1.69	2.45	1.07	1.38	1.23	1.23
mesenchymal precursor cell - adipose, donor2	11748-123G2	87.62	3.27	1.09	2.00	0.91	1.09	1.09	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	98.14	3.73	2.90	2.48	1.66	1.24	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	163.09	2.95	1.97	3.09	1.40	0.70	1.55	0.98
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	127.48	4.43	2.70	1.73	0.58	0.58	1.73	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	88.84	1.39	7.63	5.55	4.16	4.16	2.78	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	91.65	1.89	1.54	3.43	2.23	0.69	1.37	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	139.86	4.49	3.80	2.19	2.76	1.38	1.50	1.27
mesenchymal precursor cell - cardiac, donor3	11754-123G8	135.95	4.64	2.12	1.86	0.93	0.80	1.72	1.06
mesenchymal precursor cell - cardiac, donor4	11755-123G9	177.71	6.21	2.84	3.11	1.62	1.35	2.57	1.49
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	163.74	5.55	2.56	2.56	1.00	1.42	1.85	1.56
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	60.27	2.63	2.96	1.98	1.65	0.99	1.65	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	161.48	3.60	2.77	1.94	0.69	1.52	2.35	1.94
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	146.61	6.63	11.52	3.14	2.79	4.89	2.09	1.75
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	146.39	2.45	1.84	2.65	1.22	1.43	1.43	1.22
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	98.13	2.52	7.19	8.27	6.11	5.03	1.08	1.80
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	141.21	3.52	2.17	2.59	1.34	0.93	0.72	0.83
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	72.96	3.88	8.44	3.65	3.65	2.28	1.60	1.60
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	174.12	3.36	3.78	2.94	0.42	1.26	2.10	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	147.50	4.78	2.54	1.94	1.34	1.05	2.54	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	127.88	4.64	2.71	3.24	0.70	1.23	0.96	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	123.33	3.31	6.26	2.58	2.58	1.47	1.47	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	98.44	4.01	6.01	6.01	4.01	3.43	2.86	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	174.72	13.47	11.79	2.53	2.53	4.63	2.95	2.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	115.54	2.74	5.02	0.91	2.28	0.91	0.91	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	108.45	2.30	4.60	2.56	3.58	0.51	1.53	1.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	122.50	2.36	2.88	2.09	3.40	2.09	1.31	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	116.76	3.08	6.78	2.46	3.70	1.23	1.54	1.54
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	114.38	5.65	7.06	4.24	2.82	2.59	2.12	2.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	106.61	5.42	4.40	2.03	4.40	3.05	1.35	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	119.46	3.14	4.32	3.54	1.18	2.36	0.39	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	98.24	2.78	3.71	5.10	3.24	1.85	0.46	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	131.23	4.33	4.61	3.46	1.73	1.73	2.02	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	113.11	2.90	2.45	2.90	2.23	1.56	1.34	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	115.61	2.64	5.53	3.36	1.20	1.68	1.92	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	104.87	2.20	1.47	2.20	0.73	0.73	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	100.36	3.69	4.36	3.36	3.69	2.01	0.34	2.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	105.21	0.82	6.55	1.23	2.46	2.46	1.64	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	97.08	2.58	4.30	1.29	2.15	1.29	1.29	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	95.70	0.00	10.94	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	77.47	5.16	10.33	0.00	5.16	5.16	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	83.15	1.95	6.17	3.57	4.87	0.97	1.30	1.62
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	96.03	0.00	10.18	1.45	2.91	1.45	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	101.29	0.00	6.40	6.40	2.13	0.53	2.13	2.13
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	76.05	3.27	5.72	2.45	6.54	0.82	0.82	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	78.91	0.39	7.39	3.11	3.89	2.72	3.11	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	67.16	6.30	2.10	0.00	4.20	2.10	4.20	6.30
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	77.49	0.00	6.95	0.00	0.99	1.99	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	90.58	4.77	4.77	0.00	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	70.56	0.59	2.96	6.52	4.15	1.19	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	115.75	1.22	3.66	2.44	7.31	2.44	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	96.27	0.63	5.07	5.07	4.43	2.53	1.27	3.17
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	48.63	0.69	2.76	1.03	2.07	1.38	0.00	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	64.48	0.00	2.15	2.15	0.00	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	47.90	3.99	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	37.88	0.00	3.44	0.00	3.44	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	52.16	0.81	0.81	0.00	0.81	0.81	0.81	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	50.05	3.18	5.56	0.79	1.59	2.38	0.79	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	45.39	1.77	1.18	0.59	2.36	0.59	1.77	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	43.95	3.43	2.49	2.18	1.25	0.31	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	50.79	2.67	4.01	2.67	0.00	0.00	1.34	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	81.60	2.37	0.00	0.00	2.37	2.37	3.55	3.55
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	64.20	0.00	7.70	0.00	2.57	2.57	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	74.35	3.44	0.69	0.69	2.07	2.07	2.07	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	64.32	1.48	0.99	1.48	1.98	0.99	0.99	1.48
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	65.05	1.12	3.36	0.00	3.36	1.12	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	59.79	2.54	3.82	1.27	2.54	1.27	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	62.06	3.63	3.22	2.01	2.82	2.42	0.81	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	56.70	4.36	2.18	0.00	0.00	0.00	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	69.69	7.60	6.34	1.27	3.80	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	48.55	1.21	2.43	1.21	2.43	0.61	0.00	2.43
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	40.67	0.00	9.04	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	30.48	0.00	3.29	0.00	2.47	0.82	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	34.33	0.40	0.60	0.40	1.59	0.00	0.20	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	57.44	1.30	2.92	1.30	2.60	0.32	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	71.30	0.00	5.09	2.04	1.02	3.06	3.06	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	81.24	0.00	0.77	0.00	0.00	0.00	0.00	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	124.50	1.65	0.94	1.18	2.83	0.47	0.71	0.94
mesothelioma cell line:ACC-MESO-4	10494-107B8	65.33	0.93	1.85	0.46	0.46	0.93	0.46	0.93
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	153.85	12.82	8.55	4.27	4.27	4.27	17.09	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	83.54	6.58	6.17	5.86	2.98	3.49	2.26	2.16
mesothelioma cell line:Mero-25	10850-111F4	78.30	4.54	4.09	1.82	0.91	1.36	0.91	1.59
mesothelioma cell line:Mero-41	10851-111F5	103.41	5.13	6.11	2.20	1.71	0.98	1.22	1.96
mesothelioma cell line:Mero-48a	10852-111F6	151.24	5.09	5.09	2.44	1.77	1.77	1.55	0.44
mesothelioma cell line:Mero-82	10853-111F7	79.10	2.63	3.15	1.84	1.05	1.58	1.84	2.37
mesothelioma cell line:Mero-83	10854-111F8	133.96	5.62	5.45	5.96	4.77	4.26	2.38	2.55
mesothelioma cell line:Mero-84	10855-111F9	113.75	3.03	5.56	2.78	2.78	4.30	1.52	0.25
mesothelioma cell line:Mero-95	10856-111G1	79.71	3.52	4.14	2.90	1.86	1.45	1.45	1.86
mesothelioma cell line:NCI-H2052	10847-111F1	200.93	6.13	8.45	5.63	3.31	5.30	4.64	3.64
mesothelioma cell line:NCI-H226	10846-111E9	86.51	4.34	4.34	3.26	1.81	2.35	2.17	1.63
mesothelioma cell line:NCI-H2452	10848-111F2	79.43	2.22	3.76	2.22	1.54	2.05	0.68	1.02
mesothelioma cell line:NCI-H28	10845-111E8	102.30	4.83	4.33	2.80	1.02	4.33	0.25	2.04
mesothelioma cell line:No36	10857-111G2	108.95	3.91	4.24	3.26	1.96	3.91	1.96	0.98
mesothelioma cell line:ONE58	10858-111G3	89.14	5.69	7.32	2.98	2.17	2.98	1.63	2.17
migratory langerhans cells, donor1	11901-125F2	143.56	2.49	8.06	3.65	1.92	1.73	2.49	0.77
migratory langerhans cells, donor2	11902-125F3	142.02	1.10	3.30	2.08	1.34	1.10	1.22	0.61
migratory langerhans cells, donor3	11903-125F4	112.35	0.18	2.69	1.44	2.87	0.36	0.54	1.44
mixed mullerian tumor cell line:HTMMT	10689-109F5	38.20	2.61	2.29	0.65	0.65	1.31	1.31	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	88.59	2.54	1.70	1.48	1.48	0.85	1.27	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	93.06	0.23	0.69	0.00	1.15	0.23	0.23	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	98.57	1.90	1.90	1.52	2.66	0.38	0.95	0.76
myelodysplastic syndrome cell line:SKM-1	10772-110F7	169.45	1.29	2.40	2.96	1.85	0.55	0.74	1.48
myeloma cell line:PCM6	10474-106I6	90.14	1.19	1.38	0.99	1.58	0.79	0.79	0.99
myxofibrosarcoma cell line:MFH-ino	10600-108E6	102.47	0.00	4.57	1.01	1.52	0.51	0.51	2.54
myxofibrosarcoma cell line:NMFH-1	10684-109E9	250.27	3.14	3.33	3.14	3.73	1.77	1.96	2.16
nasal epithelial cells, donor1, tech_rep1	12226-129F3	61.28	1.00	0.33	1.23	0.89	0.22	0.45	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	52.07	0.59	0.88	1.25	0.29	0.51	0.15	0.29
nasal epithelial cells, donor2	12227-129F4	108.74	1.66	0.00	0.55	0.55	0.55	1.10	0.55
neuroblastoma cell line:CHP-134	10508-107D4	235.12	1.38	1.38	1.15	0.92	0.46	1.15	1.38
neuroblastoma cell line:NB-1	10539-107G8	346.86	2.99	3.37	2.06	1.12	0.94	0.94	2.43
neuroblastoma cell line:NBsusSR	10607-108F4	73.39	0.84	1.90	1.69	0.63	0.42	0.42	0.84
neuroblastoma cell line:NH-12	10555-107I6	244.12	4.29	3.54	2.61	0.93	1.49	1.86	2.61
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	78.52	5.22	5.46	2.61	0.71	1.66	1.66	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	100.25	5.23	3.33	3.48	2.22	2.06	2.22	1.27
neuroectodermal tumor cell line:TASK1	10774-110F9	85.94	0.81	2.21	0.81	0.40	0.81	1.81	1.61
neuroepithelioma cell line:SK-N-MC	10728-110A8	64.85	0.00	0.64	0.00	0.00	0.64	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	119.51	1.60	1.86	1.33	1.86	0.27	0.53	0.00
neutrophil PMN, donor1	12133-128D9	788.36	0.00	0.00	0.00	14.87	0.00	0.00	14.87
neutrophil PMN, donor2	12137-128E4	92.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	161.00	9.47	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	79.49	1.52	0.34	1.01	0.68	0.17	0.17	0.85
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	115.27	1.60	0.00	0.80	1.60	0.00	2.40	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	100.99	5.45	3.21	2.89	2.89	1.60	0.32	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	114.57	7.36	7.62	3.42	1.84	3.42	3.15	1.84
nucleus accumbens, adult, pool1	10037-101F1	158.98	1.69	0.66	1.87	0.56	0.56	0.56	1.12
occipital cortex - adult, donor10196	10172-103C1	74.17	2.06	2.06	2.06	0.00	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	107.08	2.42	2.15	1.34	1.34	1.07	0.81	0.54
occipital cortex, newborn, donor10223	10355-105E4	84.43	4.37	3.64	1.82	1.09	1.46	0.36	1.82
occipital lobe, adult, donor1	10076-102A4	127.26	0.00	2.89	9.71	5.77	1.31	1.05	0.79
occipital lobe, fetal, donor1	10073-102A1	117.14	1.29	3.00	3.43	1.72	2.15	0.43	1.29
occipital pole, adult, pool1	10036-101E9	119.68	1.50	0.71	0.63	0.95	0.55	0.87	0.63
olfactory region, adult	10195-103E6	118.45	2.87	2.10	1.91	1.91	1.72	1.34	1.34
optic nerve, donor1	10277-104E7	150.08	0.00	4.00	8.00	10.01	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	106.96	0.91	2.05	3.42	2.05	1.03	1.14	1.48
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	185.47	2.06	1.92	1.24	0.82	0.96	0.82	0.82
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	85.00	8.47	9.82	2.03	2.03	1.69	2.71	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	118.86	3.00	2.77	1.04	1.62	1.27	1.16	1.16
osteoclastoma cell line:Hs 706.T	10704-109H2	138.16	1.76	2.94	3.82	3.82	0.88	2.06	2.35
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	61.67	0.00	0.00	0.00	0.00	0.00	0.00	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	50.05	0.64	0.64	1.06	1.48	0.64	0.21	0.85
ovary, adult, pool1	10020-101D2	127.88	1.66	1.66	7.69	7.95	1.14	0.87	0.87
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	81.21	1.83	2.02	0.37	0.37	1.10	0.73	1.65
pancreas, adult, donor1	10049-101G4	157.09	3.76	6.58	5.64	3.76	3.76	0.94	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	69.32	1.12	2.52	1.40	3.91	1.12	1.12	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	125.72	16.01	15.50	4.26	2.73	6.98	3.58	1.87
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	131.97	3.48	3.48	1.82	2.32	1.32	1.16	0.99
paracentral gyrus, adult, pool1	10035-101E8	135.45	2.01	1.19	1.83	0.55	0.09	0.73	0.73
parietal cortex, adult, donor10258	10373-105G4	96.89	2.20	1.47	0.00	0.73	0.73	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	87.46	1.88	4.70	0.00	0.94	0.94	2.82	1.88
parietal lobe, adult, donor10252	10157-103A4	99.48	2.28	2.28	2.00	0.29	0.29	0.57	0.57
parietal lobe, adult, pool1	10034-101E7	134.91	1.06	0.35	1.15	0.35	0.44	0.44	0.97
parietal lobe, fetal, donor1	10072-101I9	91.16	3.88	2.91	3.88	0.97	2.91	0.00	1.94
parietal lobe, newborn, donor10223	10356-105E5	80.38	4.11	2.99	3.36	1.12	3.74	1.12	0.00
parotid gland, adult	10199-103F1	94.97	4.93	2.47	2.47	0.00	2.47	1.23	1.23
penis, adult	10200-103F2	78.96	1.61	3.22	6.98	1.61	1.61	0.54	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	155.07	9.48	5.95	3.72	4.65	3.72	2.79	2.79
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	90.48	3.06	2.19	0.87	1.31	0.87	1.17	0.15
pineal gland - adult, donor10196	10179-103C8	49.67	0.65	0.65	0.00	0.00	0.00	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	53.30	0.59	0.00	0.00	0.00	0.00	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	23.20	1.25	0.00	0.63	0.63	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	116.36	2.02	6.07	3.04	5.06	2.02	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	148.02	1.56	3.13	3.13	0.52	2.08	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	90.23	1.70	2.55	5.11	2.55	2.55	0.00	0.85
placenta, adult, pool1	10021-101D3	129.76	1.61	1.18	3.87	3.12	0.43	1.18	1.29
plasma cell leukemia cell line:ARH-77	10840-111E3	116.93	3.97	4.37	3.05	2.38	1.99	1.32	0.66
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	99.45	0.78	1.87	1.71	1.56	0.31	0.62	0.78
pons, adult, pool1	10033-101E6	114.47	1.29	0.26	0.26	0.86	0.26	0.86	0.43
postcentral gyrus, adult, pool1	10032-101E5	142.53	1.31	1.13	1.83	0.52	0.96	1.31	1.05
promyelocytes/myelocytes PMC, donor1	12132-128D8	269.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	110.16	0.00	0.00	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	70.41	11.74	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	53.60	1.89	1.31	1.46	0.44	0.73	0.29	0.29
prostate cancer cell line:PC-3	10439-106E7	95.65	1.82	0.54	0.18	0.91	0.36	0.18	1.27
prostate, adult, pool1	10022-101D4	95.23	1.63	1.00	3.63	3.99	0.36	0.82	0.45
putamen, adult, donor10196	10176-103C5	206.56	7.55	2.60	3.78	0.24	2.60	1.89	1.42
putamen, adult, donor10252	10152-102I8	60.78	1.96	0.00	0.00	1.96	0.00	1.96	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	51.36	1.09	4.37	1.09	1.09	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	120.08	4.11	3.14	1.21	0.72	0.48	0.97	0.24
putamen, newborn, donor10223	10365-105F5	53.98	13.49	9.75	3.75	3.75	5.25	1.50	0.00
rectal cancer cell line:TT1TKB	10469-106I1	27.64	0.00	0.58	0.00	0.29	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	126.58	1.39	0.00	0.00	1.39	2.78	0.00	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	76.96	2.33	3.18	1.48	0.64	1.48	0.21	1.48
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	66.69	3.31	1.66	0.83	0.41	1.24	0.41	0.41
retina, adult, pool1	10030-101E3	135.08	2.09	0.89	1.49	0.80	0.70	0.89	0.99
retinoblastoma cell line:Y79	10475-106I7	58.98	1.30	0.52	1.30	1.30	0.52	0.00	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	96.02	0.98	1.23	0.74	0.74	0.86	0.61	1.84
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	141.16	1.12	1.69	1.12	1.69	0.28	0.84	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	68.21	0.76	3.03	0.00	2.27	0.00	0.00	0.76
salivary acinar cells, donor1	11771-123I7	81.74	3.40	2.27	2.10	2.27	0.49	0.81	0.49
salivary acinar cells, donor2	11772-123I8	96.52	4.54	5.09	3.17	2.89	1.51	0.96	0.55
salivary acinar cells, donor3	11773-123I9	45.02	1.32	0.00	0.00	0.66	0.66	0.66	0.00
salivary gland, adult, pool1	10093-102C3	97.23	2.29	1.14	0.00	0.00	0.00	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	86.50	1.85	2.45	2.36	3.12	0.76	0.67	1.94
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	83.93	2.12	1.53	1.41	2.82	0.94	0.82	1.18
seminal vesicle, adult	10201-103F3	103.17	1.59	5.29	5.29	4.23	0.53	4.23	4.23
serous adenocarcinoma cell line:JHOS-2	10639-108I9	103.24	4.37	4.86	1.70	1.46	1.70	1.70	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	163.31	1.76	6.29	2.26	2.26	2.26	1.01	1.51
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	219.77	10.04	12.04	8.03	4.01	8.03	0.00	6.02
serous cystadenocarcinoma cell line:HTOA	10693-109F9	61.38	2.15	0.40	1.34	0.27	0.54	0.54	0.67
signet ring carcinoma cell line:Kato III	10436-106E4	131.75	1.66	1.77	2.21	2.98	0.44	0.77	1.66
signet ring carcinoma cell line:NUGC-4	10483-107A6	97.54	2.45	2.45	0.65	1.42	0.90	0.77	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	43.98	0.00	1.42	2.13	1.42	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	94.39	1.32	0.24	8.04	6.48	0.84	1.08	1.20
skeletal muscle, fetal, donor1	10066-101I3	88.44	2.01	0.00	3.02	6.03	2.01	2.01	0.00
skin, adult, donor1	10074-102A2	101.78	0.00	0.00	6.79	0.00	0.00	13.57	0.00
skin, fetal, donor1	10065-101I2	79.53	0.63	1.89	5.05	2.52	1.26	0.63	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	129.74	0.33	1.67	0.33	2.33	0.33	1.00	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	112.84	11.66	8.83	2.52	1.58	3.15	1.26	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	68.23	1.73	2.31	2.31	1.16	0.39	0.58	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	137.30	1.65	0.99	0.99	1.48	0.66	0.99	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	111.15	3.70	1.93	2.90	0.97	1.29	1.13	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	107.65	0.65	0.44	0.87	1.09	0.87	0.87	0.44
small intestine, adult, pool1	10024-101D6	211.29	2.51	3.94	12.54	12.18	1.91	1.79	4.30
small intestine, fetal, donor1	10064-101I1	99.26	3.69	2.95	3.93	0.49	3.93	0.98	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	73.34	5.64	5.64	2.05	2.56	0.51	2.56	2.05
smooth muscle, adult, pool1	10048-101G3	79.35	3.10	1.81	1.03	0.78	1.03	1.03	1.03
somatostatinoma cell line:QGP-1	10781-110G7	72.37	0.27	1.07	0.54	0.27	0.00	0.00	0.27
spinal cord - adult, donor10196	10181-103D1	86.26	5.96	4.59	1.15	0.92	3.21	1.15	0.23
spinal cord, adult, donor10252	10159-103A6	105.27	1.58	1.18	2.37	1.18	0.00	1.58	0.79
spinal cord, adult, donor10258	10369-105F9	70.56	2.77	6.23	2.08	1.38	0.69	1.38	0.00
spinal cord, fetal, donor1	10056-101H2	134.16	1.22	3.05	0.61	0.61	0.61	1.83	0.00
spinal cord, newborn, donor10223	10359-105E8	66.59	1.84	5.05	0.92	1.38	3.21	2.30	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	133.22	4.48	1.79	0.75	1.64	0.60	0.90	1.94
spleen, adult, pool1	10025-101D7	141.30	2.09	1.76	6.28	5.73	1.21	1.10	1.76
spleen, fetal, pool1	10044-101F8	145.09	2.22	1.99	2.62	0.79	0.87	0.56	1.19
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	128.36	1.35	1.55	1.14	0.83	0.83	0.83	0.93
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	43.29	0.57	0.57	0.19	0.38	0.00	0.00	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	54.51	4.54	3.15	1.40	0.00	2.45	0.70	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	70.37	3.52	0.78	0.78	1.95	1.17	0.00	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	100.85	0.56	1.13	1.01	0.90	0.68	0.68	1.01
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	84.72	2.54	2.97	0.85	1.69	0.85	2.12	1.69
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	137.92	2.12	1.69	1.27	0.42	0.00	0.42	2.96
stomach, fetal, donor1	10062-101H8	105.73	0.00	0.00	0.00	1.07	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	90.01	3.99	2.85	9.68	1.71	2.85	1.14	1.14
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	131.48	4.15	3.32	3.32	0.42	2.49	1.04	1.66
substantia nigra, adult, donor10258	10371-105G2	56.38	1.03	1.03	0.00	1.55	0.52	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	36.74	1.41	4.95	2.12	1.41	2.12	1.41	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	107.75	1.83	1.15	1.38	1.15	0.23	1.38	0.23
temporal lobe, adult, pool1	10031-101E4	177.42	2.80	1.86	2.12	0.85	0.68	0.51	1.61
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	139.60	2.85	4.27	4.99	2.85	3.56	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	123.07	0.44	6.15	1.76	1.32	0.88	0.44	0.88
tenocyte, donor1	11763-123H8	196.89	21.30	18.15	3.14	3.14	8.03	3.84	2.79
tenocyte, donor2	11765-123I1	114.83	4.96	7.63	2.29	2.29	3.05	0.00	1.14
tenocyte, donor3	11768-123I4	145.67	11.86	11.12	3.34	1.48	3.71	1.48	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	94.50	1.53	2.55	0.34	1.36	1.02	0.68	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	162.78	4.62	4.47	2.77	5.24	3.08	2.93	1.85
teratocarcinoma cell line:PA-1	10807-111A6	66.80	1.70	0.31	0.62	0.77	0.46	0.15	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	87.47	1.14	2.03	0.89	4.06	1.14	1.78	1.02
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	63.91	0.76	1.89	1.13	0.76	1.51	0.00	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	66.75	1.64	0.87	0.55	0.33	0.55	1.09	0.44
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	55.70	6.51	2.28	2.28	2.93	1.63	3.26	0.65
testis, adult, pool1	10026-101D8	112.53	3.65	2.47	14.71	16.96	1.61	0.75	1.83
testis, adult, pool2	10096-102C6	83.00	3.16	6.77	4.51	1.35	4.96	4.06	1.80
thalamus - adult, donor10196	10168-103B6	81.69	1.10	1.10	2.21	0.00	1.10	1.10	1.10
thalamus, adult, donor10252	10154-103A1	124.87	3.44	3.13	3.59	0.63	1.41	0.16	0.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	20.02	0.00	3.08	1.54	0.00	1.54	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	58.14	5.27	2.14	0.82	0.66	1.81	0.49	0.66
thalamus, newborn, donor10223	10366-105F6	60.98	2.30	4.60	2.88	1.15	1.73	0.58	0.58
throat, adult	10209-103G2	86.89	1.50	5.74	4.49	2.00	1.50	3.00	0.50
throat, fetal, donor1	10061-101H7	84.40	2.13	1.52	0.61	0.00	1.22	0.61	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	120.43	4.17	3.97	1.59	0.79	1.99	1.19	2.78
thymus, adult, pool1	10027-101D9	190.08	4.57	3.98	16.50	13.62	2.29	1.99	1.19
thymus, fetal, pool1	10043-101F7	138.61	1.97	1.25	3.32	1.45	1.14	0.62	1.14
thyroid carcinoma cell line:KHM-5M	10776-110G2	90.28	4.92	3.72	2.66	2.66	1.33	1.99	1.33
thyroid carcinoma cell line:TCO-1	10783-110G9	84.93	2.24	0.98	0.84	0.42	1.12	1.12	0.84
thyroid, adult, pool1	10028-101E1	124.29	1.59	1.59	5.69	4.39	0.65	0.75	0.93
thyroid, fetal, donor1	10060-101H6	78.84	3.95	1.32	1.05	1.32	1.05	0.79	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	107.79	0.00	3.08	0.00	0.00	0.00	3.08	0.00
tongue, adult	10203-103F5	94.89	4.19	4.19	9.54	2.79	2.79	1.16	1.86
tongue, fetal, donor1	10059-101H5	76.45	1.97	1.97	0.79	0.39	1.58	1.58	0.00
tonsil, adult, pool1	10047-101G2	163.19	2.10	1.90	2.70	1.40	0.80	0.60	1.20
trachea, adult, pool1	10029-101E2	134.07	2.62	1.39	4.17	2.78	0.49	0.82	1.23
trachea, fetal, donor1	10058-101H4	86.94	1.15	1.15	1.54	3.08	2.69	1.15	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	111.24	2.48	1.42	0.71	1.77	1.42	1.42	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	170.01	1.93	1.93	2.13	1.62	0.81	1.11	1.42
transitional-cell carcinoma cell line:JMSU1	10492-107B6	63.93	1.88	2.19	2.19	3.76	0.94	0.94	0.63
tridermal teratoma cell line:HGRT	10694-109G1	68.49	0.00	5.71	0.00	3.81	0.00	1.90	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	118.17	2.45	2.03	1.19	2.20	1.02	0.68	1.27
umbilical cord, fetal, donor1	10057-101H3	79.29	8.35	2.09	2.09	0.00	0.00	0.00	4.17
uterus, adult, pool1	10100-102D1	111.59	1.54	0.85	1.54	1.19	0.51	0.34	0.68
uterus, fetal, donor1	10055-101H1	106.48	2.05	1.54	1.54	1.02	0.51	1.54	0.00
vagina, adult	10204-103F6	80.77	0.65	0.65	1.94	3.88	1.29	1.29	1.94
vein, adult	10191-103E2	105.22	5.92	5.92	8.99	3.51	4.16	1.75	1.97
xeroderma pigentosum b cell line:XPL 17	10563-108A5	116.16	1.87	1.07	1.34	0.53	1.60	0.27	0.27